Alexandra L. Hanlon

Current Funding:

• Co-Investigator (PI: Bickel) National Institute of Health/ UL1TR003015, The Integrated Translational Health Research Institute of Virginia (iTHRIV). $14,423, February 2019 to January 2024. (Code: UL1)
• Co-Investigator (PI: Gooneratne), National Institute of Health/NINR R01AG054435-01, Changing the Trajectory of Mild Cognitive Impairment with CPAP Treatment of Obstructive Sleep Apnea. $80,295, September 2018 to November 2023. (Code: R01)
• Co-Investigator (PI: Richards), National Institute of Health/NINR R01AG051588-01A1, Nighttime Agitation and Restless Legs Syndrome in People with Alzheimer’s Disease. $33,035, February 2017 to March 2021. (Code: R01)
• Co-Investigator (PI: Fogel), National Institute of Health/NHLBI R01HL090615, Cerebral Anatomy, Hemodynamics and Metabolism In Single Ventricles: Relationship to Neurodevelopment. $23,958, October 2015 to June 2020. (Code: R01)

Completed Funded Grants:

• Co-Investigator (PI: Hodgson), National Institute of Health/NINR R01NR015226-01A1, The Role of Palliative Care Interventions to Reduce Circadian Rhythm Disorders in Persons with Dementia. $311,327, September 2016 to January 2019. (Code: R01)
• Co-investigator (PI: Ulrich), National Institute of Health/NINR R01-CA196131. Retention in Cancer Clinical Trials: Modeling Patient-Participants’ Risk-Benefit Assessments. $283,278, December 2014 to January 2019. (Code R01)
• Principal Investigator, University of Pennsylvania Research Funds, Quantifying the Effects of Sleep on Cardiovascular Health Risk Factors: A Population Analysis using UK Biobank Data. $50,000, July 2016 to July 2018. (Code O)
• Co-Investigator (PI: Villarruel), National Institute of Health/NINR R01NR013505, Testing a Latino Web-based Parent-Adolescent Sexual Communication Intervention. $313,695, September 2012 to June 2017. (Code: R01)
• Bio-Statistician (PI: Chirinos), National Institute of Health /NHLBI R56HL124073, Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease. $375,530, September 2015 to August 2016. (Code: R56)
• Bio-statistician (PI: Heil), National Institute of Health/NINR R44-NR013609, Technology Application to Enhance Discharge Referral Decision Support. $552,960, September 2014 to August 2016. (Code O)
• Bio-Statistician (PI: Fogel), National Institute of Health /NHLBI R01HL090615, Cerebral Anatomy, Hemodynamics and Metabolism In Single Ventricles: Relationship to Neurodevelopment. $16,171, October 2015 to June 2016. (Code: R01)
• Bio-Statistician (Co- PI: Villarruel), National Institute of Health /NINR R01NR013505, Testing a Latino Web-based Parent-Adolescent Sexual Communication Intervention. $313,695, September 2012 to June 2016. (Code: R01)
• Bio-statistician (PI: Kim), National Institute of Health/NINR R00-NR013177-03, An Objective Snoring Index and Its Association with Carotid Atherosclerosis. $155,669, September 2013 to June 2016. (Code O)
• Statistician (PI: Buttenheim), National Institute of Health /NICHD, Vaccination Status of Children Exempted from School-Entry Immunization Mandates. $50,000, July 2014 to April 2016. (Code: R03)
• Co-investigator (PI: Medoff-Cooper), National Institute of Health/NINR R01NR002093, Feeding Behaviors and Energy Balance in Infants with CHD. $3,144,501 (CHOP direct cost), July 2011 to March 2016. (Code R01)
• Bio-statistician (PI: Brawner), CDC/NCHHSTP/U01PS003304, PS11-003 Minority AIDS Research Initiative. $132,896, January 2012 to December 2015. (Code O)
• Co-investigator (PI: Thompson), National Institute of Health/NCI 2P30CA016520-35, Abramson Cancer Center Support Grant – Biostatistics Core. $375,070 (sub only), December 2010 to November 2015. (Code PP)
• Co-investigator (PI: Rhodes), National Institute of Health/NIAAA R01AA018705-02, A RCT of Brief Intervention for Problem Drinking and Partner Violence. $320,192, September 2010 to May 2015. (Code R01)
• Statistician (PI: Liu), National Institute of Health/NIEHS 5R01ES018858-04, Lead exposure, externalizing behavior, and neurobiological mediating factors. $200,475, September 2011 to April 2015. (Code R01)
• Principal Investigator, Robert Wood Johnson Foundation Health & Society Scholars Program, Effects of Chronotype on Sleep Duration and Body Composition Variables. $12,835, October 2013 to August 2014. (Code O)
• Bio-statistician (PI: Souders), Department of the Army, Tailored Behavioral Intervention for Insomnia in Children with Autism Spectrum Disorders. $99,983.92, July 2013 to June 2014. (Code FG)
• Statistician (PI: Richards), National Institute of Health / NIA, Mild Cognitive Impairment and Obstructive Sleep Apnea. $499,987, April 2011 to March 2014. (Code R01)
• Statistician (PI: Naylor), Jointly sponsored by the Gordon & Betty Moore Foundation, the Jonas Center for Nursing Excellence, and the Alex & Rita Hillman Foundation, Effects of Patient Centered Medical Home Plus Transitional Care for Complex Older Adults. $497,778, August 2011 to July 2014.
• Statistician (PI: Hirshman), National Institute of Health, Palliative needs of cognitively impaired patients during health care transactions. $100,000, August 2011 to June 2013. (Code: R03)
• Statistician (PI: Kim), National Institute of Health /NINR K99-NR013177-02, An Objective Snoring Index and Its Association with Carotid Atherosclerosis. $85,450. September 2011 to April 2013. (Code K99/R00)
• Statistician (PI: Chirinos), National Institute of Health/NHLBI R01-HL-080076-04, Inflammatory response to sleep apnea in obese subjects. $498,280, May 2006 to April 2013. (Code R01)
• Co-investigator (PI: Medoff-Cooper), CHOP, Improving feeding for the late preterm infant-a pilot study. $45,724, January 2011 to November 2012. (Code: O)
• Co-investigator (PI: Naylor), National Institute of Health/NIA R01AG025524-05, Health Related Quality of Life: Elders in long-term care. $370,355, September 2006 to May 2012. (Code R01)
• Co-investigator (PI: Naylor), PENN, Marian S. Ware Alzheimer Program, Continuity of Care Component. $270,832, July 2009 to April 2012. (Code PG)
• Co-investigator (PI: M. Brown), National Institute of Health/NHBLI R01HL085497, Genetics of In Vivo and In Vitro Endothelial Function in African Americans. $2,234,111, April 2007 to March 2012*. (Code R01) *Consultant post January 2009.
• Co-investigator (PI: D. Nelson), National Institute of Health/DHHS 5 R01 HD038856-07, BV-associated Bacteria and Adverse Pregnancy Outcomes among Urban Women. $1,892,384, April 2008 to March 2012*. (Code R01) *Consultant post January 2009.
• Co-investigator (PI: Bowles), Edna G. Kynett Memorial Foundation, Getting the Right Care for the Right Patient: Breaking the Cycle of Heart Failure Readmission. $30,500, November 2010 to October 2011. (Code O)
• Co-investigator (PI: A. Hausman), National Institute of Health/Center for Disease Control U49CE001093-01, Violence Prevention Center Research. $140,357, September 2006 to August 2011*. (Code O) *Consultant post January 2009.
• Co-investigator (PI: Bruner), National Institute of Health/NCI R21CA140766-02, Randomized Feasibility Study of Dilator Use and an Educational Program to Increase Compliance After Vaginal Brachytherapy for Endometrial Cancer. $144,742, September 2009 to August 2011. (Code FG)
• Co-investigator (PI: Medoff-Cooper), Cardiac Center Pilot Funds, The Children’s Hospital of Philadelphia: Sleep Patterns and Maternal Stress. $25,000, September 2009 to August 2011. (Code O)
• Co-investigator (PI: Meghani), National Institute of Health/NINR 1RC1NR011591-01, A Novel Approach to Elucidate Mechanisms for Disparity in Cancer Pain Outcomes. $282,001, January 2010 to July 2011. (Code FG)
• Co-investigator (PI: Rhodes), National Institute of Health/NCMHD RC1MD004415-02, Community Health Center Intervention to Prevent Family Violence. $348,870, September 2009 to July 2011. (Code FG)
• Statistician (PI: Riegel), National Institute of Health/NHLBI R01-HL084394-03, Impact of sleepiness on heart failure self-care. $666,327, April 2007 to March 2011. (Code R01)
• Statistician (PI: Sawyer), National Institute of Health K99NR011173-01, Risk Assessment and Tailored Intervention to Improve CPAP Adherence. $90,000, April 2009 to March 2011. (Code TG)
• Co-investigator (PI: Ulrich), Pennsylvania Tobacco Funds, Radiation Therapy Oncology Group: Attrition in Radiation Therapy Oncology Trials: A 20 Year Retrospective Review. $26,137, January 2007 to December 2010. (Code O)
• Co-investigator (PI: N. Martin), National Institute of Health/DHHS 2 R01 DC001924-12A2, Lexical Retrieval, Verbal Short Term Memory and Learning. $456,100, May 2005 to November 2010*. (Code R01) *Consultant post January 2009.
• Co-investigator (PI: Watkins-Bruner), National Institute of Health/NCI R01 R01 CA114321-03, Ethnic Differences in Media Response & Recruitment. $638,888, September 2006 to August 2010. (Code R01)
• Co-investigator (PI: Medoff-Cooper), Cardiac Center Pilot Funds, The Children’s Hospital of Philadelphia. $25,000, September 2010 to August 2010. (Code O)
• Co-investigator (PI: A. Bove), AHRQ/DHHS 1R18HS017202-01, Using a Telemedicine System to Promote Patient Care Among Underserved Individuals. $1,197,247, September 2007 to August 2010*. (Code FG) *Consultant post January 2009.
• Co-investigator (PI: Neiman), Pennsylvania Department of Health, Commonwealth Universal Research Enhancement (C.U.R.E.) Program – Project 2: Identifying Interventions for Cancer Patients at High Risk for Poor Outcomes. $17,966 (sub-only), January 2010 to June 2010. (Code O)
• Co-investigator (PI: G. Boden), Pennsylvania Department of Health MSA Funds, Community & Internet-Based Treatment for Obese Adults with CVD Risk. $4,151,920, June 2006 to May 2010*. (Code R01) *Consultant post January 2009.
• Co-investigator (PI: Naylor), National Institute of Health 5R01AG025524-04, $575,117, June 2009 to May 2010. (Code R01)
• Statistician (PI: Bowles), National Institute of Health/NINR R01 NR-008923-04, Promoting Self-Care with Telehomecare: Impact on Outcomes. $285,726, January 2010 to May 2010. (Code R01)
• Co-investigator (PI: J. Masalko), National Institute of Mental Health RO3MH080820, Cohort Study of Lifecourse Patterns of Religious Service Attendance and Risk of Psychopathology. $100,000, August 2008 to April 2010*. (Code PP) *Consultant post January 2009.
• Statistician (PI: Neiman), Pennsylvania Department of Health, Commonwealth Universal Research Enhancement (C.U.R.E.) Program – Project 1: Factors Associated with Attrition in Radiation Therapy Oncology Trials: A 20 Year Review. $26,137 (sub only), January 2010 to January 2010. (Code O)
• Statistician (PI: Molinoff), Pennsylvania Department of Health, Identification of Barriers and Facilitators to Oncology Clinical Trials Recruitment. $79,000 (sub only), January 2006 to December 2009. (Code O).
• Co-investigator (PI: Medoff-Cooper), National Institute of Health/NINR R01 NR/HL02093, Feeding Behaviors and Energy Cost in Infants with CHD. $881,736.33, September 2002 to May 2009. (Code R01)
• Co-investigator (PI: S. Belenko), National Institute of Health/DHHS 7 R01 DA020346-03, The Risk of Sexually Transmitted Disease Among Adolescents Involved in the Juvenile Justice System. $202,907, August 2006 to July 2008. (Code R01)
• Co-investigator (PI: S. Lepore), National Institute of Health/National Cancer Institute 7 R01 CA104223-04, Prostate Cancer Education in African-American Men. $500,122, September 2004 to June 2008. (Code R01)
• Co-investigator (PI: B. Collins), Pennsylvania Department of Health MSA Funds, Behavioral Mechanism of Cue Exposure Treatment for Smoking Relapse Prevention: A Feasibility Trial with Bupropion. $50,000, August 2006 to January 2008. (Code O)
• Co-investigator (PI: J. Gold), National Institute of Health/National Institute for Occupational Safety and Health K01 OH008134-01A1, Skin Temperature in the Hands of Office Worker. $147,750, September 2005 to August 2006. (Code TG)
• Co-investigator (PI: R. Young), National Institutes of Health P30 CA06927, Comprehensive Cancer Center Program. Core Grant funds, August 2000 to June 2005. (Code PP)
• Co-investigator (PI: A. Pollack), National Institute of Health/DHHS R01 CA101984, Radiation, Hormones & Antisense Prostate Cancer Therapy. September 2003 to June 2005. (Code R01)
• Co-Investigator (PI: D. Bruner), Department of Defense DAMD17-02-1-0055. Preferences and Utilities for Prostate Cancer Screening and Treatment: Assessment of the Underlying Decision Making Process. January 2002 to June 2005. (Code FG)
• Co-investigator (PI: D. Bruner), American Cancer Society RPG-00-208-01-CCE, Improving Time Trade-off for Utility Analysis of Prostate Cancer Therapies. $438,000, July 2000 to June 2004. (Code PG)
• Principal Investigator, Department of Defense DAMD17-01-1-0056, Hierarchical Nonlinear Mixed Effect Modeling: Defining Post-Radiation Therapy Relapse in Prostate Cancer Patients. $98,000, July 2001 to June 2003. (Code FG)
• Co-Investigator (PI: D. Bruner), Oncology Nursing Foundation/Amgen Inc, Research Grant, FCCC IRB#97-827. Determination of Preferences and Utilities for the Treatment of Prostate Cancer. May 1998 to May 2000. $8500, May 1998 to May 2000. (Code O)
• Co-investigator (PI: G. Hanks), National Cancer Institute Research Grant CA65435, Patterns of Care Study in Radiation Oncology. $650,000 per year, October 1994 to October 1997. (Code PP)
• Co-investigator (PI: G. Hanks), National Cancer Institute Contract N01CM87275, Continuation Funds Agency for Health Care Policy and Research. Patterns of Care Study in Radiation Oncology. $4,000,000, October 1988 to October 1994. (Code PP)

• Riegel B, Daus M, Lozano AJ, Malone SK, Patterson F, Hanlon A.. Shift Workers Have Higher Blood Pressure Medicine Use, But Only When They Are Short Sleepers: A Longitudinal UK Biobank Study. J Am Heart Assoc. 2019 Oct 15;8(20):e013269.
• Hayat MJ, Staggs VS, Schwartz TA, Higgins M, Azuero A, Budhathoki C, Chandrasekhar R, Cook P, Cramer E, Dietrich MS, Garnier-Villarreal M, Hanlon A. He J, Hu J, Kim M, Mueller M, Nolan JR, Perkhounkova Y, Rothers J, Schluck G, Su  X, Templin TN, Weaver MT, Yang Q, Ye S. Moving nursing beyond p < .05. Nurs Outlook. 2019 Sep - Oct;67(5):509-510.
• Riegel B, Hanlon A., Coe NB, Hirshman KB, Thomas G, Stawnychy M, Wald JW, Bowels KH. Health coaching to improve self-care of informal caregivers of adults with chronic heart failure- iCare4Me: Study protocol for a randomized controlled trial. Conte,p Clin Trials. 2019 Sep 6; 85:105845.
• Xiao C, Bruner DW, Dai T, Guo Y, Hanlon A. A Comparison of Missing-Data Imputation Techniques in Exploratory Factor Analysis. J Nurs Meas. 2019 Aug 1;27(2):313-334.
• Petrovsky DV, Sefcik JS, Hanlon A., Lozano AJ, Cacchione PZ. Social Engagement, Cognition, Depression, and Comorbidity in Nursing Home Residents with Sensory Impairment. Res Gerontol Nurs. 2019 Sept 1;12(5):217-226.
• Brewster GS, Hirschman KB, Riegel BJ, Hanlon A., Huang L, McPhillips MV, Abbott KM, Naylor MD. Association of health-related quality of life domains with daytime sleepiness among elderly recipients of long-term services and supports. Geriatr Nurs. 2019 Jul - Aug;40(4):417-423.
• Hayat MJ, Staggs VS, Schwartz TA, Higgins M, Azuero A, Budhathoki C, Chandrasekhar R, Cook P, Cramer E, Dietrich MS, Garnier-Villarreal M, Hanlon A. He J, Hu J, Kim M, Mueller M, Nolan JR, Perkhounkova Y, Rothers J, Schluck G, Su X, Templin TN, Weaver MT, Yang Q, Ye S. (2019). Moving nursing beyond p < .05. Int J Nurs Stud. 2019 May 28.
• Agawu A, Hanlon A., Buttenheim AM, Song L, Fiks AG, Feemster KA. Disparities in Human Papillomavirus Vaccine Series Completion by Adolescent Males: A Retrospective Cohort Study. Acad Pediatr. 2019 May 18.
• Polonsky HM, Bauer KW, Fisher JO, Davey A, Sherman S, Abel ML, Hanlon A. Ruth KJ, Dale LC, Foster GD. Effect of a Breakfast in the Classroom Initiative on Obesity in Urban School-aged Children: A Cluster Randomized Clinical Trial. JAMA Pediatr. 2019 Apr 1;173(4):326-333.
• Richards KC, Gooneratne N, Dicicco B, Hanlon A. Moelter S, Onen F, Wang Y, Sawyer Weaver T, Lozano A, Carter P, Johnson J. (2019). CPAP Adherence May Slow 1-Year Cognitive Decline in Older Adults with Mild Cognitive Impairment and Apnea. J Am Geriatr Soc. 2019 Mar;67(3):558-564. doi: 10.1111/jgs.15758.
• Pellegrin K, Lozano A, Miyamura J, Lynn J, Krenk L, Jolson-Oakes S, Ciarleglio A, McInnis T, Bairos A, Gomez L, Benitez-McCrary M, Hanlon A. (2019). Community-acquired and hospital-acquired medication harm among older inpatients and impact of a state-wide medication management intervention. BMJ Qual Saf. 2019 Feb;28(2):103-110.
• Hirschman KB, Toles MP, Hanlon A., Huang L, Naylor MD. (2019). What Predicts Health Care Transitions for Older Adults Following Introduction of LTSS? J Appl Gerontol. 2019 Feb
• Brawner BM, Jemmott LS, Wingood G, Lozano AJ, Hanlon A.. (2019). Project GOLD: A pilot randomized controlled trial of a novel psychoeducational HIV/STI prevention intervention for heterosexually-active black youth. Res Nurs Health. 2019 Feb;42(1):8-28.
• Mnatzaganian CL, Lozano AJ, Pellegrin KL, Miyamura J, Knox MA, Hanlon A.. (2019). Acute respiratory and cardiovascular outcomes associated with low levels of ambient fine particular matter (PM_2.5) on the island of Oahu. In Bui, TX & Sprague, RH (Eds.), Proceedings of the 52^nd Hawaii International Conference on System Sciences (pp.3761-3768).
• Varas-Díaz N, Betancourt-Díaz E, Lozano AJ, Huang L, DiNapoli L, Hanlon A. Villarruel AM. (2019). Testing the efficacy of a web-based parent-adolescent sexual communication intervention among Puerto Ricans. Fam Community Health. 2019 Jan/Mar;42(1):30-43.
• Lach HW, Lozano AJ, Hanlon A., Cacchione PZ. (2019). Fear of falling in sensory impaired nursing home residents. Aging Ment Health. Jan 9:1-7.
• Greenle MM, Hirschman KB, Coburn K, Marcantonio S, Hanlon A., Naylor M, Mauer E, Ulrich C. (2019). End-of-life Health-Care Utilization Patterns Among Chronically Ill Older Adults. Am J Hosp Palliat Care. 2019 Jan 29:1049909118824962
• Wright EN, Hanlon A. Lozano A, Teitelman AM. (2018). The association between intimate partner violence and 30-year cardiovascular disease risk among young adult women. J Interpers Violence. 2018 Dec 7:886260518816324.
• Riegel B, Huang L, Mikkelsen ME, Kutney-Lee A, Hanlon A., Murtaugh CM, Bowles KH. (2018). Early post-intensive care syndrome among older adult sepsis survivors receiving home care. J Am Geriatr Soc. 2018 Nov 30.
• Greene MZ, Hughes TL, Hanlon A. Huang L, Sommers MS, Meghani SH. (2018). Predicting cervical cancer screening among sexual minority women using classification and regression tree analysis. Prev Med Rep. 2018 Nov 12;13:153-159.
• Irving SY, Daly B, Verger J, Typpo KV, Brown AM, Hanlon A. Weiss SL, Fitzgerald JC, Nadkarni VM, Thomas NJ, Srinivasan V. (2018). The association of nutrition status expressed as body mass index z score with outcomes in children with severe sepsis: A secondary analysis from the sepsis prevalence, outcomes, and therapies (SPROUT) study. Sepsis prevalence, outcomes, and therapies (SPROUT) study investigators and pediatric acute lung injury and sepsis investigators (PALISI) network. Crit Care Med. 2018 Nov;46(11):e1029-e1039.
• You AS, Fukunaga BT, Hanlon A., Lozano AJ, Goo RA. (2018). The Daniel K. Inouye College of Pharmacy Scripts: The effects of vancomycin use and de-escalation in patients hospitalized with pneumonia. Hawaii J Med Public Health. 2018 Oct;77(10):261-267.
• Pauly MV, Hirschman KB, Hanlon A., Huang L, Bowles KH, Bradway C, McCauley K, Naylor MD. (2018). Cost impact of the transitional care model for hospitalized cognitively impaired older adults. J Comp Eff Res. 2018 Sep 11.
• Earl-Royal EC, Kaufman EJ, Hanlon A., Holena DN, Rising KL, Kit Delgado M. (2018). Corrigendum to factors associated with hospital admission after an emergency department treat and release visit for older adults with injuries. Am J Emerg Med. 2018 Sep;36(9):1724-1725.
• Ulrich CM, Deshmukh S, Pugh SL, Hanlon A. Grady C, Watkins Bruner D, Curran W. (2018). Attrition in NRG oncology's radiation-based clinical trials. Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):26-33.
• Greene MZ, Hughes TL, Sommers MS, Hanlon A. Meghani SH. (2018). Association of pregnancy history and cervical cancer screening in a community sample of sexual Minority women. J Womens Health (Larchmt). 2018 Aug 17.
• Long AS, Hanlon A., Pellegrin KL. (2018). Socioeconomic variables explain rural disparities in US mortality rates: Implications for rural health research and policy. SSM Popul Health. 2018 Aug 31;6:72-74.
• Villarruel AM, Varas-Díaz N, Hanlon A. Betancourt E, Lozano A, DiNapoli L. (2018). Use of web-based parent–adolescent health promotion program among Puerto Ricans. Nursing Research. 2018 July 31.
• Patterson F, Lozano A, Huang L, Perkett M, Beeson J, Hanlon A. (2018). Towards a demographic risk profile for sedentary behaviours in middle-aged British adults: a cross-sectional population study. BMJ Open. 2018 Jul 6;8(7):e019639.
• VonHoltz LAH, Frasso R, Golinkoff JM, Lozano AJ, Hanlon A. Dowshen N. (2018). Internet and social media access among youth experiencing homelessness: mixed-methods study. J Med Internet Res. 2018 May 22;20(5):e184.
• Ma GX, Lee MM, Tan Y, Hanlon A., Feng Z, Shireman TI, Rhee J, Wei Z, Wong F, Koh HS, Kim C, York W. (2018). Efficacy of a community-based participatory and multilevel intervention to enhance hepatitis B virus screening and vaccination in underserved Korean Americans. Cancer. 2018 Mar 1;124(5):973-982.
• Palmer JD, Schneider CJ, Hockstein N, Hanlon A., Silberg J, Strasser J, Mauer EA, Dzeda M, Witt R, Raben A. (2018). Combination of post-operative radiotherapy and cetuximab for high-risk cutaneous squamous cell cancer of the head and neck: A propensity score analysis. Oral Oncol. 2018 Mar;78:102-107.
• Chase, J.D, Russell, D, Huang, L, Hanlon, A, O’Connor, M, Bowles, KH. (2018). Relationships between race/ethnicity and health care utilization among older post- acute home health care patients. J Appl Gerontol. 2018 Feb 1:733464818758453.
• Keddem S, Frasso R, Dichter M, Hanlon A. (2018). The association between pregnancy intention and breastfeeding. J Hum Lact. 2018 Feb;34(1):97-105.
• Chase JD, Lozano A, Hanlon A. Bowles KH. (2018). Identifying factors associated with mobility decline among hospitalized older adults. Clin Nurs Res. 2018 Feb;27(1):81-104.
• MacKenzie MA, Hanlon A. (2018). Health-care utilization after hospice enrollment in patients with heart failure and cancer. Am J Hosp Palliat Care. 2018 Feb;35(2):229-235.
• Garcia RM, Hanlon A. Small W, Strauss JB, Lin L, Wells J, Bruner DW. (2018). The relationship between body mass index and sexual function in endometrial cancer. Oncol Nurs Forum. 2018 Jan 1;45(1):25-32.
• Liu J, Cui Y, Li L, Wu L, Hanlon A. Pinto-Martin J, Raine A, Hibbeln JR. (2017). The mediating role of sleep in the fish consumption - cognitive functioning relationship: a cohort study. Sci Rep. 2017 Dec 21;7(1):17961.
• Golfenshtein N, Hanlon A., Deatrick JA, Medoff-Cooper B. (2017). Parenting stress in parents of infants with congenital heart disease and parents of healthy infants: The first year of life. Compr Child Adolesc Nurs. 2017 Dec;40(4):294-314.
• Chirinos DA, Gurubhagavatula I, Broderick P, Chirinos JA, Teff K, Wadden T, Maislin G, Saif H, Chittams J, Cassidy C, Hanlon A., Pack AI. (2017). Depressive symptoms in patients with obstructive sleep apnea: biological mechanistic pathways. J Behav Med. 2017 Dec;40(6):955-963.
• Jain S, Gurubhagavatula I, Townsend R, Kuna ST, Teff K, Wadden TA, Chittams J, Hanlon A., Maislin G, Saif H, Broderick P, Ahmad Z, Pack AI, Chirinos JA. (2017). Effect of continuous positive airway pressure, weight loss, continuous positive airway pressure lus weight loss on central hemodynamics and arterial stiffness. Hypertension. 2017 Dec;70(6):1283-1290.
• Shukla G, Sarkar A, Hanlon A. Crockett E, Chen HC, Martelli-Raben J, Glick A, Benge B, Lobis M, Terranova S, Desperito T, Cozzolino D, Kemmerer E, Mourtada F, Raben A. (2017). Brachytherapy. 2017 May - Jun;16(3):490-496.
• Earl-Royal EC, Kaufman EJ, Hanlon A., Holena DN, Rising KL, Kit Delgado M. (2017). Factors associated with hospital admission after an emergency department treat and release visit for older adults with injuries. Am J Emerg Med. 2017 Sep;35(9):1252-1257.
• Lenhart CM, Wiemken A, Hanlon A. Perkett M, Patterson F. (2017). Perceived neighborhood safety related to physical activity but not recreational screen-based sedentary behavior in adolescents. BMC Public Health. 2017 Sep 18;17(1):722.
• Ricco A, Hanlon A. Lanciano R. (2017). Propensity score matched comparison of intensity modulated radiation therapy vs stereotactic body radiation therapy for localized prostate cancer: A survival analysis from the national cancer database. Front Oncol. 2017 Aug 31;7:185.
• Knafl GJ, Barakat LP, Hanlon A., Hardie T, Knafl KA, Li Y, Deatrick JA. (2017). Adaptive modeling: An approach for incorporating nonlinearity in regression analyses. Res Nurs Health. 2017 Jun;40(3):273-282.
• Stewart JM, Hanlon A. Brawner BM. (2017). Predictors of HIV/AIDS Programming in african american churches: Implications for HIV prevention, testing, and care. Health Educ Behav. 2017 Jun;44(3):385-393.
• Chase JD, Huang L, Russell D, Hanlon A. O'Connor M, Robinson KM, Bowles KH. (2017). Racial/ethnic disparities in disability outcomes among post-acute home care patients. J Aging Health. 2017 Jun 1:898264317717851.
• Chase JD, Hirschman KB, Hanlon A., Huang L, Bowles KH, Naylor MD. (2017). Physical functioning among older adults new to long-term services and supports. Gerontologist. 2017 May 25.
• Malone SK, Patterson F, Lozano A, Hanlon A. (2017). Differences in morning-evening type and sleep duration between Black and White adults: Results from a propensity-matched UK Biobank sample. Chronobiol Int. 2017;34(6):740-752.
• O'Connor M, Hanlon A. Mauer E, Meghani S, Masterson-Creber R, Marcantonio S, Coburn K, Van Cleave J, Davitt J, Riegel B, Bowles KH, Keim S, Greenberg SA, Sefcik JS, Topaz M, Kong D, Naylor M. (2017). Identifying distinct risk profiles to predict adverse events among community-dwelling older adults. Geriatr Nurs. 2017 May 4. pii: S0197-4572(17)30067-8.
• Toles M, Moriarty H, Coburn K, Marcantonio S, Hanlon A. Mauer E, Fisher P, O'Connor M, Ulrich C, Naylor MD. (2017). Managing chronic illness. J Appl Gerontol. 2017 Apr;36(4):462-479.
• Kim J, Pack AI, Riegel BJ, Chirinos JA, Hanlon A. Lee SK, Shin C. (2017). Objective snoring time and carotid intima-media thickness in non-apneic female snorers. J Sleep Res. 2017 Apr;26(2):14 150.
• Hanlon A. Small W, Strauss J, Lin LL, Hanisch L, Huang L, Bai J, Wells J, Bruner DW. (2017). Dilator use after vaginal brachytherapy for endometrial cancer: A randomized feasibility and adherence study. Cancer Nurs. 2017 Apr 21.
• Patterson F, Malone SK, Grandner MA, Lozano A, Perkett M, Hanlon A. (2017). Interactive effects of sleep duration and morning/evening preference on cardiovascular risk factors. Eur J Public Health. 2017 Mar 27.
• Ahmad S, Ricco A, Brown R, Hanlon A. Yang J, Feng J, Stanley M, Buonocore R, Okpaku A, Arrigo S, Lamond J, Brady L, Lanciano R. (2017). Single institutional experience of stereotactic radiosurgery alone for first brain metastatic event and salvage of second brain metastatic event in a community setting with review of the literature. Front Oncol. 2017 Mar 9;7:32.
• Pellegrin KL, Krenk L, Oakes SJ, Ciarleglio A, Lynn J, McInnis T, Bairos AW, Gomez L, McCrary MB, Hanlon A., Miyamura J. (2017). Reductions in medication-related hospitalizations in older adults with medication management by hospital and community pharmacists: A quasi-experimental study. J Am Geriatr Soc. 2017 Jan;65(1):212-219.
• Hanlon, A. “The Collaborating Statistician: Publishing in a Peer Review Journal.”  Stattrak.amstat.org. American Statistical Association. March 1, 2016. http://stattrak.amstat.org/2016/03/01/hanloncollab16/  (Invited Article)
• Medoff-Cooper B, Irving SY, Hanlon A., Golfenshtein N, Radcliffe J, Stallings VA, Marino BS, Ravishankar C. (2016). The Association among feeding mode, growth, and developmental outcomes in infants with complex congenital heart disease at 6 and 12 months of age. J Pediatr. Feb;169:154-159.
• Rearden J, Hanlon A., Ulrich C, Brooks-Carthon M, Sommers M. (2016). Examining differences in opportunity and eligibility for cancer clinical trial participation based on sociodemographic and disease characteristics. Oncol Nurs Forum. Jan 1;43(1):57-66.
• Hasan S, Ricco A, Jenkins K, Lanciano R, Hanlon A. Lamond J, Yang J, Feng J, Good M, Noumoff J, Brady L. (2016). Survival and control prognosticators of recurrent gynecological malignancies of the pelvis and para-aortic region treated with stereotactic body radiation therapy. Front Oncol. 2016;6: 249.
• Singh A, Bodukam V, Saigal K, Bahl J, Wang Y, Hanlon A. Lu Y, Davis M. (2016). Identifying risk factors associated with inappropriate use of acid suppressive therapy at a community hospital. Gastroentrol Res Pract. 2016; 7.
• Patterson F, Malone SK, Lozano A, Grandner MA, Hanlon A.. (2016). Smoking, screen-based sedentary behavior, and diet associated with habitual sleep duration and chronotype: Data from the UK Biobank. Ann Behav Med. 2016 Oct;50(5):715-726.
• Hallowell SG, Rogowski JA, Spatz DL, Hanlon A., Kenny M, Lake ET. (2016). Factors associated with infant feeding of human milk at discharge from neonatal intensive care: Cross-sectional analysis of nurse survey and infant outcomes data. Int J Nurs Stud. Jan;53:190-203.
• Ricco A, Manahan G, Lanciano R, Hanlon A. Yang J, Arrigo S, Lamond J, Feng J, Mooreville M, Garber B, Brady L. (2016). The comparison of stereotactic body radiation therapy and intensity-modulated radiation therapy for prostate cancer by NCCN risk groups. Front Oncol. 2016 Aug 23;6:184.
• Stewart JM, Hanlon A. Brawner BM. (2016). Predictors of HIV/AIDS programming in African American churches: Implications for HIV prevention, testing, and care. Health Educ Behav. 2016 Aug 17.
• Matura LA, McDonough A, Hanlon A., Carroll DL. (2016). Developmental and initial validation of the pulmonary arterial hypertension symptom inference scale. J Nurs Meas. 2016;24(1):40-53.
• Naylor MD, Hirschman KB, Hanlon A., Bowles KH, Bradway C, McCauley KM, Pauly MV. (2016). Effects of alternative interventions among hospitalized, cognitively impaired older adults. J Comp Eff Res. 2016 May;5(3):259-72.
• Patterson F, Malone SK, Lozano A, Grandner MA, Hanlon A.. (2016). Smoking, screen-based sedentary behavior, and diet associated with habitual sleep duration and chronotype: Data from the UK Biobank. Ann Behav Med. 2016 Apr 7.
• D'Emic N, Engelman A, Molitoris J, Hanlon A. Sharma NK, Moeslein FM, Chuong MD. (2016). Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy. J Gastrointest Oncol. 2016 Apr;7(2):269-77.
• Al Sawah S, Compher CW, Hanlon A., Lipman TH. (2016). 25-Hydroxyvitamin D and glycemic control: A cross-sectional study of children and adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2016 May;115:54-9.
• Oliai C, Bernetich M, Brady L, Yang J, Hanlon A. Lamond J, Arrigo S, Good M, Mooreville M, Garber B, Lanciano R. (2016). Propensity score matched comparison of SBRT versus IMRT for the treatment of localized prostate cancer. J Radiat Oncol. 2016;5:187-195.
• Naylor MD, Hirschman KB, Hanlon A., Abbott KM, Bowles KH, Foust J, Shah S, Zubritsky C. (2016). Factors associated with changes in perceived quality of life among elderly recipients of long-term services and supports. J Am Med Dir Assoc. 2016 Jan;17(1):44-52.
• Hess LM, Huang HQ, Hanlon A., Robinson WR, Johnson R, Chambers SK, Mannel RS, Puls L, Davidson SA, Method M, Lele S, Havrilesky L, Nelson T, Alberts DS. (2015). Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study. Gynecol Oncol. Dec;139(3):541-5.
• Malone SK, Patterson F, Lu Y, Lozano A, Hanlon A. (2015). Ethnic differences in sleep duration and morning-evening type in a population sample. Chronobiol Int. 2015 Dec 10:1-12.
• Buttenheim AM, Sethuraman K, Omer SB, Hanlon A., Levy MZ, Salmon D. (2015). MMR vaccination status of children exempted from school-entry immunization mandates. Vaccine. 2015 Nov 17;33(46):6250-6.
• Liu J, Cao S, Chen Z, Raine A, Hanlon A. Ai Y, Zhou G, Yan C, Leung PW, McCauley L, Pinto-Martin J; Jintan Cohort Study Group. (2015). Cohort Profile Update: The China Jintan Child Cohort Study. Int J Epidemiol. 2015 Oct;44(5):1548-1548l.
• Toles M, Moriarty H, Coburn K, Marcantonio S, Hanlon A. Mauer E, Fisher P, O'Connor M, Ulrich C, Naylor MD. (2015). Managing chronic illness: Nursing contact and participant enrollment in a Medicare care coordination demonstration program. J Appl Gerontol. 2015 Aug 31.
• Fowble B, Park C, Wang F, Peled A, Alvarado M, Ewing C, Esserman L, Foster R, Sbitany H, Hanlon A. (2015). Rates of reconstruction failure in patients undergoing immediate reconstruction with tissue expanders and/or implants and postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):634-41.
• Heal C, Ding W, Lamond J, Wong M, Lanciano R, Su S, Yang J, Feng J, Arrigo S, Markiewicz D, Hanlon A. Brady L. (2015). Definitive treatment of early-stage non-small cell lung cancer with stereotactic ablative body radiotherapy in a community cancer center setting. Front Oncol. 2015 Jun 30;5:146.
• Azzam G, Lanciano R, Arrigo S, Lamond J, Ding W, Yang J, Hanlon A. Good M, Brady L. (2015). SBRT: An opportunity to improve quality of life for oligometastatic prostate cancer. Front Oncol. 2015 May 5;5:101.
• Hasan S, Chen E, Lanciano R, Yang J, Hanlon A. Lamond J, Arrigo S, Ding W, Mikhail M, Ghaneie A, Brady L. (2015). Salvage fractionated stereotactic radiotherapy with or without chemotherapy and immunotherapy for recurrent Glioblastoma Multiforme: A single institution experience. Front Oncol. 2015 May 15;5:106.
• Martino K, Wagner M, Froh EB, Hanlon A., Spatz DL. (2015). Postdischarge breastfeeding outcomes of infants with complex anomalies that require surgery. J Obstet Gynecol Neonatal Nurs. 2015 Apr 9.
• Bowles KH, Chittams J, Heil E, Topaz M, Rickard K, Bhasker M, Tanzer M, Behta M, Hanlon A.. (2015). Successful electronic implementation of discharge referral decision support has a positive impact on 30- and 60-day readmissions. Res Nurs Health. 38(2):102-14.
• Matura LA, McDonough A, Hanlon A., Carroll DL. (2015). Development and initial psychometric properties of the Pulmonary Arterial Hypertension Symptom Scale (PAHSS) (2015). Appl Nurs Res. 28(1):42-7.
• Bernetich M, Oliai C, Lanciano R, Hanlon A. Lamond J, Arrigo S, Yang J, Good M, Feng J, Brown R, Garber B, Mooreville M, Brady LW. (2014). SBRT for the primary treatment of localized prostate cancer: The effect of gleason score, dose and heterogeneity of intermediate risk on outcome utilizing 2.2014 NCCN risk stratification guidelines. 4:312.
• Wilmoth MC, Hanlon A., Ng LS, Bruner DW. (2014). Factor analysis of the modified sexual adjustment questionnaire-male. J Nurs Meas. 22(2):241-54.
• Chirinos JA, Gurubhagavatula I, Teff K, Rader DJ, Wadden TA, Townsend R, Foster GD, Maislin G, Saif H, Broderick P, Chittams J, Hanlon A., Pack AI. (2014). CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med. 370(24):2265-75.
• Hallowell SG, Spatz DL, Hanlon A., Rogowski JA, Lake ET. (2014). Characteristics of the NICU work environment associated with breastfeeding support. Adv Neonatal Care. 14(4):290-300.
• Somanathan S, Jacobs F, Wang Q, Hanlon A., Wilson JM, Rader DJ. (2014). AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in Mouse Models of Familial Hypercholesterolemia. Circ Res. 115(6):591-9.
• Moré JM, Eclov NC, Chung MP, Wynne JF, Shorter JH, Nelson DD, Hanlon A., Burmeister R, Banos P, Maxim PG, Loo BW, Diehn M. (2014). Feasibility and potential utility of multicomponent exhaled breath analysis for predicting development of radiation pneumonitis after stereotactic ablative radiotherapy. J Thorac Oncol. 9(7):957-64.
• Matura LA, McDonough A, Hanlon A., Carroll DL, Riegel B. (2014). Sleep disturbance, symptoms, psychological distress, and health-related quality of life in pulmonary arterial hypertension. Eur J Cardiovasc Nurs. pii: 1474515114537951.
• Naylor MD, Hirschman KB, Hanlon A., Bowles KH, Bradway C, McCauley KM, Pauly MV. (2014). Comparison of evidence-based interventions on outcomes of hospitalized, cognitively impaired older adults. J Comp Eff Res. 3(3):245-57.
• Shultz DB, Jang SS, Hanlon A., Diehn M, Loo BW, Maxim PG. (2014). The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy. Pract Radiat Oncol. 4(3):192-7.
• Ali NK, Ferguson RP, Mitha S, Hanlon A. (2014). Do medical trainees feel confident communicating with low health literacy patients? J Community Hosp Intern Med Perspect.14:4.
• Chakravorty S, Hanlon A., Kuna ST, Ross RJ, Kampman KM, Witte LM, Perlis ML, Oslin DW. (2014). The effects of quetiapine on sleep in recovering alcohol-dependent subjects: A pilot study (2014). J Clin Psychopharmacol. 2014 Jun;34(3):350-4.
• Rhodes KV, Rodgers M, Sommers M, Hanlon A. Crits-Christoph P. (2014). The Social Health Intervention Project (SHIP): Protocol for a randomized controlled clinical trial assessing the effectiveness of a brief motivational intervention for problem drinking and intimate partner violence in an urban emergency department. BMC Emerg Med. 14(1):10.
• O'Connor M, Hanlon A. Bowles KH. (2014). Impact of frontloading of skilled nursing visits on the incidence of 30-day hospital readmission. Geriatr Nurs. 35(2 Suppl):S37-44.
• Sawyer AM, King TS, Hanlon A. Richards KC, Sweer L, Rizzo A, Weaver TE. (2014). Risk assessment for CPAP nonadherence in adults with newly diagnosed obstructive sleep apnea: preliminary testing of the Index for Nonadherence to PAP (I-NAP). Sleep Breath. 2014 Dec;18(4):875-83.
• Kim GJ, Koshy M, Hanlon A., Horiba MN, Edelman MJ, Burrows WM, Battafarano RJ, Suntharalingam M. (2014). The benefit of chemotherapy in esophageal cancer patients with residual disease after trimodality therapy. Am J Clin Oncol. 2016 Apr;39(2):136-41.
• Ulrich CM, Zhou QP, Hanlon A. Danis M, Grady C. (2014). The impact of ethics and work-related factors on nurse practitioners' and physician assistants' views on quality of primary healthcare in the United States. Appl Nurs Res.
• Harris JP, Murphy JD, Hanlon A., Le QT, Loo BW, Diehn M. (2014). A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 88(4):872-84.
• Shankar KN, Hirschman KB, Hanlon A., Naylor MD. (2014). Burden in caregivers of cognitively impaired elderly adults at time of hospitalization: a cross-sectional analysis. J Am Geriatr Soc. 62(2):276-84.
• Xiao C, Bruner DW, Jennings BM, Hanlon A.. (2014). Methods for examining cancer symptom clusters over time. Res Nurs Health. 37(1):65-74.
• Mahoney AD, Pinto-Martin J, Hanlon A. (2014). Home environment, brain injury, & school performance in LBW survivors. MCN Am J Matern Child Nurs. 39(1):18-25.
• Nelson DB, Hanlon A. Nachamkin I, Haggerty C, Mastrogiannis DS, Liu C, Fredricks DN. (2014). Early pregnancy changes in bacterial vaginosis-associated bacteria and preterm delivery. Paediatr Perinat Epidemiol. Epub 2014 Jan 9.
• Bowles KH, Hanlon A. Holland D, Potashnik SL, Topaz M. (2014). Impact of discharge planning decision support on time to readmission among older adult medical patients. Prof Case Manag. 19(1):29-38.
• Liu J, Hanlon A. Ma C, Zhao SR, Cao S, Compher C. (2014). Low blood zinc, iron, and other sociodemographic factors associated with behavior problems in preschoolers. Nutrients. 6(2):530-45.
• Xiao, C, Hanlon A. Zhang Q, Movsas B, Ang K, Rosenthal DI, Nguyen-Tan PF, Kim H, Le Q, Bruner DW. (2014). Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129. Cancer, 120:848–854.
• Meghani SH, Chittams J, Hanlon A., Curry J. (2013). Measuring preferences for analgesic treatment for cancer pain: How do african-americans and whites perform on choice-based conjoint (CBC) analysis experiments?  BMC Med Inform Decis Mak.13(1):118.
• Radhakrishnan K, Bowles K, Hanlon A. Topaz M, Chittams J. (2013). A retrospective study on patient characteristics and telehealth alerts indicative of key medical events for heart failure patients at a home health agency. Telemed J E Health.19(9):664-70.
• Riegel B, Hanlon A., Zhang X, Fleck D, Sayers SL, Goldberg LR, Weintraub WS. (2013). What is the best measure of daytime sleepiness in adults with heart failure? J Am Assoc Nurse Pract. 25(5):272-9.
• Polomano RC, Buckenmaier CC 3rd, Kwon KH, Hanlon A., Rupprecht C, Goldberg C, Gallagher RM. (2013). Effects of low-dose IV ketamine on peripheral and central pain from major limb injuries sustained in combat. Pain Med. 14(7):1088-100.
• Kuna ST, Benca R, Kushida CA, Walsh J, Younes M, Staley B, Hanlon A. Pack AI, Pien GW, Malhotra A. (2013). Agreement in computer-assisted manual scoring of polysomnograms across sleep centers. Sleep. 36(4):583-9.
• Malhotra A, Younes M, Kuna ST, Benca R, Kushida CA, Walsh J, Hanlon A. Staley B, Pack AI, Pien GW. (2013). Performance of an automated polysomnography scoring system versus computer-assisted manual scoring. Sleep. 36(4):573-82.
• Sarkar A, Donavanik V, Zhang I, Chen H, Koprowski C, Hanlon A. Mourtada F, Strasser J, Raben A. (2013). Prostate implant dosimetric outcomes and migration patterns between bio-absorbable coated and uncoated brachytherapy seeds. Brachytherapy. 12(4):356-61.
• Mahmood U, Hanlon A., Koshy M, Buras R, Chumsri S, Tkaczuk KH, Cheston SB, Regine WF, Feigenberg SJ. (2012). Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol. 20(5):1436-43.
• Xiao C, Hanlon A. Zhang Q, Ang K, Rosenthal DI, Nguyen-Tan PF, Kim H, Movsas B, Bruner DW. (2012). Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. Oral Oncol. 49(4):360-6.
• Steis MR, Evans L, Hirschman KB, Hanlon A. Fick DM, Flanagan N, Inouye SK. (2012). Screening for delirium using family caregivers: convergent validity of the family confusion assessment method and interviewer-rated confusion assessment method. J Am Geriatr Soc. 60(11):2121-6.
• Guidera M, McCool W, Hanlon A. Schuiling K, Smith A. (2012). Midwives and liability: results from the 2009 nationwide survey of certified nurse-midwives and certified midwives in the United States. Journal of Midwifery & Women's Health, 57(4):345-352.
• Vandergrift JL, Gold JE, Hanlon A. Punnett L. (2012). Physical and psychosocial ergonomic risk factors for low back pain in automobile manufacturing workers. Occupational & Environmental Medicine, 69(1):29-34.
• Maselko J, Hayward RD, Hanlon A. Buka S, Meador K. (2012). Religious service attendance and major depression: a case of reverse causality? American Journal of Epidemiology, 175(6):576-583.
• Patterson F, Seravalli L, Hanlon A. Nelson DB. (2012). Neighborhood safety as a correlate of tobacco use in a sample of urban pregnant women. Addict Behav. 37(10):1132-7.
• Abbott KM, Bettger JP, Hanlon A. Hirschman KB. (2012). Factors associated with health discussion network size and composition among elderly recipients of long-term services and supports. Health Commun. 27(8):784-793.
• Sell NK, Giarelli E, Blum N, Hanlon A., Levy SE. (2012). Comparison of autism spectrum disorder DSM-IV criteria and associated features among african american and white children in Philadelphia County. Disabil Health J. 5(1):9-17.
• Compher CW, Hanlon A. Kang Y, Elkin L, Williams NN. (2012). Attendance at clinical visits predicts weight loss after gastric bypass surgery. Obes Surg. 22(6), 927-934.
• Turaka A, Buyyounouski MK, Hanlon A., Horwitz EM, Greenberg RE, Movsas B. (2012). Hypoxic prostate/muscle po(2) ratio predicts for outcome in patients with localized prostate cancer: long-term results. Int J Radiat Oncol Biol Phys. 282(3):433-9.
• Hirschman KB, Abbott KM, Hanlon A., Prvu Bettger J, Naylor MD. (2012). What factors are associated with having an advance directive among older adults who are new to long term care services? J Am Med Dir Assoc. 13(1):82.7-11.
• Choi JN, Hanlon A. Leffell D. (2011). Melanoma and nevi: detection and diagnosis. Curr Probl Cancer 2011; 35: 138-161.
• Bowles KH, Hanlon A., Glick HA, Naylor MD, O'Connor M, Riegel B, Shih NW, Weiner MG. (2011). Clinical effectiveness, access to, and satisfaction with care using a telehomecare substitution intervention: a randomized controlled trial. Int J Telemed Appl. Vol 2011 Article ID 540138, 13 pages.
• Ward L, Patel NM, Hanlon A. Eldakar-Hein S, Sherlinski K, Ward SH. (2011). Prescription medication borrowing among adult patients at an urban medical center. J Urban Health. 88(6):997-1014.
• Teitelman AM, Stringer M, Nguyen GT, Hanlon A., Averbuch T, Stimpfel AW. (2011).  Social cognitive and clinical factors associated with HPV vaccine initiation among urban, economically disadvantaged women. J Obstet Gynecol Neonatal Nurs. 40(6):691-701.
• Husain ZA, Mahmood U, Hanlon A. Neuner G, Buras R, Tkaczuk K, Feigenberg SJ. (2011). Accelerated partial breast irradiation via brachytherapy: a patterns-of-care analysis with ASTRO consensus statement groupings. Brachytherapy. 10(6):479-85.
• Liu J, Ai YX, Hanlon A. Shi Z, Dickerman B, Compher C. (2011). Micronutrients deficiency and associated sociodemographic factors in chinese children. World J Pediatr. 7(3):217-23.
• Granda-Cameron C, Hanlon A., Lynch MP, Houldin A. (2011). Experience of newly diagnosed patients with sarcoma receiving chemotherapy. Oncol Nurs Forum. 38(2),160-9.
• Cuellar NG, Hanlon A. Ratcliffe SJ. (2011). The relationship with iron and health outcomes in persons with restless legs syndrome. Clin Nurs Res. 20(2):144-61.
• Spiliopoulos M, Kareti A, Jain NJ, Kruse LK, Hanlon A. Dandolu V. (2011). Risk of peripartum hysterectomy by mode of delivery and prior obstetric history: data from a population-based study. Arch Gynecol Obstet. 283(6):1261-8.
• Harner H, Hanlon A., Garfinkel M. (2010). Effect of Iyengar yoga on mental health of incarcerated women: A Feasibility Study. Nursing Research. 59(6):389-99.
• Roberts KJ, Lepore SJ, Hanlon A., Helgeson V. (2010). Genitourinary functioning and depressive symptoms over time In younger versus older men treated for prostate cancer. Annals of Behavioral Medicine. 40(3):275-83.
• Bauerle Bass S, Burt Ruzek S, Ward L, Gordon TF, Hanlon A. Hausman AJ, Hagen M (2010). If you ask them, will they come? Predictors of quarantine compliance during a hypothetical avian influenza pandemic: results from a statewide survey. Disaster Medicine and Public Health Preparedness 4(2), 135-44.
• Patterson F, Wileyto EP, Segal J, Kurz J, Glanz K, Hanlon A. (2010). Intention to quit smoking: role of personal and family member cancer diagnosis. Health Education Research. 25(5), 792-802. Epub 2010 Jun 2.
• Torowicz D, Irving SY, Hanlon A., Sumpter DF, Medoff-Cooper B. (2010). Infant temperament and parental stress in 3-month-old infants after surgery for complex congenital heart disease. Journal of Developmental and Behavioral Pediatrics. 31(3), 202-8.
• Gold JE, Piligian G, Glutting JJ, Hanlon A. Frings-Dresen MH, Sluiter JK. (2010). Cluster analysis of symptoms among patients with upper extremity musculoskeletal disorders. Journal of Occupational Rehabilitation. 20(4):526-36.
• Riegel B, Hanlon A., McKinley S, Moser DK, Meischke H, Doering LV, Davidson P, Pelter MM, Dracup K. (2010). Differences in mortality in acute coronary syndrome symptom clusters. American Heart Journal. 195(3), 392-8.
• Hanrahan NP, Aiken LH, McClaine L, Hanlon A.. (2010). Relationship between psychiatric nurse work environments and nurse and nurse burnout in acute care general hospitals. Issues in Mental Health Nursing. 31(3), 198-207.
• Ko EC, Koprowski CD, Dickson-Witmer D, Penman E, Sorensen M, Hanlon A., Sammons S, Frach A, Strasser J. (2010). Partial vs. whole breast irradiation in a community hospital: a retrospective cohort analysis of 200 patients. Brachytherapy. 9(3), 248-53.
• Kozin SH, Boardman MJ, Chafetz RS, Williams GR, Hanlon A. (2010). Arthroscopic treatment of internal rotation contracture and glenohumeral dysplasia in children with brachial plexus birth palsy. Journal of Shoulder & Elbow Surgery, 19(1),102-10.
• Friedenberg FK, Hanlon A. Vanar V, Nehemia D, Mekapati J, Nelson DB, Richter JE. (2010). Trends in gastroesophageal reflux disease as measured by the national ambulatory medical care survey. Digestive Diseases & Sciences Journal, 55(7),1911-7.
• Meghani SH, Lee CS, Hanlon A., Bruner D. (2009). Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities. BMC Medical Informatics & Decision Making, 27(9), 47.
• Hausman AJ, Hohl B, Hanlon A., Becker J, Branas CC, Hayden UT, Thomas N, Fein JA. (2009). Translating community-specified indicators of program success into measurable outcomes. Journal of Public Health Management & Practice, 15(6), 22-30.
• Benge B, Donavanik V, Sammons S, Glick A, Sarkar A, Townsend M, Hanlon A. Koprowski P, Raben A, Kattepogu K. (2009). 5 year clinical outcomes for organ confined low, intermediate, and high risk prostate cancer treated with PSI +/- ERT: The Christiana health care experience. Delaware Medical Journal, 81(5), 189-93.
• Gold JE, Cherniack M, Hanlon, A, Dennerlein JT,  Dropkin J. (2009). Skin temperature in the dorsal hand of office workers and severity of upper extremity musculoskeletal disorders. International Archives of Occupational & Environmental Health, 82(10), 1281-92.
• Schulman EA, Peterlin BL, Lake AE, Lipton RB, Hanlon A. Siegel S, Levin M, Goadsby PJ Markley HG. (2009). Defining refractory Migraine: Results of the RHSIS survey of American Headache Society members. Headache, 49(4), 509-18.
• Nelson DB, Hanlon A. Hassan, S, Britto J, Geifman-Holtzman O, Haggerty C, Fredricks DN. (2009). Preterm labor and bacterial vaginosis-associated bacteria among urban women. Journal of Perinatal Medicine, 37(2),130-4.
• Thunfors P, Collins BN, Hanlon A.. (2009). Health behavior interests of adolescents with unhealthy diet and exercise: Implications for weight management. Health Education Research, 24(4), 634-45.
• Uscher-Pines L, Hanlon A., Nelson DB. (2009). Racial differences in bacterial vaginosis among pregnant women: The relationship between demographic and behavioral predictors and individual BV-related microorganism levels. Maternal & Child Health Journal, 13(4), 512-9.
• Trabulsi EJ, Valicenti RK, Hanlon A., Pisansky TM, Sandler HM, Kuban DA, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Lin DW, Anscher MS, Slawin KM, Roehrborn CG, Forman JD, Liauw SL, Kestin LL, Deweese TL, Scardino PT, Stephenson AJ, Pollack A. (2008). A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology, 72(6), 1298-302.
• Belenko S, Dembo R, Weiland D, Rollie M, Salvatore C, Hanlon A. Childs K. (2008). Recently arrested adolescents are at high risk for sexually transmitted diseases. Sexually Transmitted Disease Journal, 35, 758-63.
• Hellstrom MK, McClain PK, Schallhorn, RG, Bellis L, Hanlon A., Ramberg P. (2008). Local minocycline as an adjunct to surgical therapy in moderate to severe, chronic periodontitis. Journal of Clinical Periodontology, 35, 525-31.
• Mu Z, Hachem P, Hensley H, Stoyanova R, Kwon H, Hanlon A., Agrawal S, Pollack A. (2008). Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo. The Prostate, 68, 599-609.
• Friedenberg FK, Palit A, Parkman HP, Hanlon A. Nelson DB. (2008). Botulinum toxin A for the treatment of delayed gastric emptying. The American Journal of Gastroenterology, 103, 416-23.
• Williams SG, Buyyounouski MK, Pickles T, Kestin L, Martinez A, Hanlon A., Duchesne GM. (2008). Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3264 men: Statistical significance without predictive performance. International Journal of Radiation Oncology, Biology, & Physics, 70, 1169-75.
• Buyyounouski MK, Hanlon A., Horwitz EM, Pollack A. (2008). Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapy. International Journal of Radiation Oncology, Biology, & Physics, 70, 59-66.
• Raben A, Sammons S, Sim S, Chen H, Hanlon A. Sarkar A, Donavanik V, Grebler A, Geltzeiler J, Benge B, Glick A, Jacob D, Koprowski, P. (2007). Initial comparison of inverse optimization, modified peripheral technique, and geometric optimization as real-time intraoperative computer planning options for permanent seed implantation of the prostate. Brachytherapy, 6, 238-45.
• Konski A, Speier W, Hanlon A., Beck JR, Pollack A. (2007). Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate? Journal of Clinical Oncology, 25(24), 3603-8.
• Morgan PB, Hanlon A., Horwitz EM, Buyyounouski MK, Uzzo RG, Pollack A. (2007). Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy. Cancer,110, 68-80.
• Alcantara P, Hanlon A., Buyyounouski MK, Horwitz EM, Pollack A. (2007). Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death. Cancer, 109, 41-47.
• Feng M, Hanlon, AL, Pisansky TM, Kuban D, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Pollack A, Kestin LL, Valicenti RK, Deweese TL, Sandler HM. (2007). Predictive Factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. International Journal of Radiation Oncology, Biology, & Physics, 68, 1417-23.
• Eade TN, Hanlon A., Horwitz EM, Buyyounouski MK, Hanks GE, Pollack A. (2007). What dose of external-beam radiation is high enough for prostate cancer? International Journal of Radiation Oncology, Biology, & Physics, 68, 682-9.
• Bass SB, Ruzek SB, Gordon TF, Hanlon A.. (2007). Preparedness for a smallpox outbreak: comparing metrics for assessing levels of vaccination among health-care workers by state. Epidemiology Infection Journal, 135, 622-33, 2007.
• Morgan PB, Hanlon A., Horwitz EM, Buyyounouski MK, Uzzo RG, Pollack A. (2007). Radiation dose and late failures in prostate cancer. International Journal of Radiation Oncology, Biology, & Physics, 67, 1074-81.
• D’Ambrosio DJ, Hanlon A., Al-Saleem T, Feigenberg SJ, Horwitz EM, Uzzo RG, Pollack A, Buyyounouski MK. (2007). The proportion of prostate biopsy tissue with gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer. International Journal of Radiation Oncology, Biology, & Physics, 67, 1082-7.
• Feigenberg SJ, Hanlon A., Langer C, Goldberg M, Nicolaou N, Millenson M, Coia LR, Lanciano R, Movsas B. (2007). A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and III A non-small cell lung cancer. Journal of Thoracic Oncology, 2, 287-92.
• Feigenberg SJ, Hanlon A., Horwitz EM, Uzzo RG, Eisenberg D. (2006). A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL is clinically significant after external beam radiotherapy for prostate cancer. American Journal of Clinical Oncology, 29, 458-62.
• Konski A, Watkins-Bruner D, Feigenberg S, Hanlon A., Kulkami S, Beck JR, Horwitz EM, Pollack A. (2006). Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. International Journal of Radiation Oncology, Biology, & Physics,66(2), 408-15, 2006.
• Konski A, Eisenberg D, Horwitz E, Hanlon A., Pollack A, Hanks GE. (2006). Does age matter in the selection of treatment for men with early-stage prostate cancer? Cancer, 106(12), 2598-602.
• Freedman GM, Anderson PR, Eisenberg DF, Hanlon A., Wang L, Nicolaou N. (2006).  Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. American Journal of Clinical Oncology, 29(1),66-70.
• Chawla SN, Crispen PL, Hanlon A., Greenberg RE, Chen DY, Uzzo RG. (2006). The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. Journal of Urology, 175(2), 425-431.
• Berger AC, Sigurdson ER, LeVoyer T, Hanlon A., Mayer RJ, MacDonald JS, Catalano PJ, Haller DG. (2006). Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. Journal of Clinical Oncology, 23(34), 8706-12.
• Pollack A, Hanlon A., Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg R.E., Uzzo RG, Ma CM, McNeeley SW, Buyyounouski MK, Price RA. (2006). Dosimetry and preliminary acute toxicity in the first 100 mean treated for prostate cancer on a randomized hypofractionation dose escalation trial. International Journal of Radiation Oncology, Biology & Physics, 64(2), 518-526.
• Siegelmann-Danieli N, Ben-Izhack O, Hanlon A., Ridge JA, Stein ME, Khandelwal V, Langer CJ. (2005). P53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposure.Tumori, 91(4), 346-50.
• Diratzouian H, Freedman GM, Hanlon A., Eisenberg DF, Anderson PR. (2005). Importance of physical examination in the absence of a mammographic abnormality for the detection of early-stage breast cancer. Clinical Breast Cancer, 6(4), 330-333.
• Buyyounouski MK, Hanlon A., Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG, Pollack A. (2005). Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer. International Journal of Radiation Oncology, Biology, & Physics, 63(5), 1455-1462.
• Andrews SF, Horwitz EM, Feigenberg SJ, Eisenberg DF, Hanlon A., Uzzo RG, Pollack A. (2005). Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma? Cancer, 104(2), 299-304.
• Feigenberg SJ, Hanlon A., Horwitz EM, Uzzo RG, Eisenberg D, Pollack A. (2005). Long-term androgen deprivation increases grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy. International Journal of Radiation Oncology, Biology, & Physics, 62(2), 397-405.
• Freedman GM, Anderson PR, Hanlon A., Eisenberg DF, Nicolaou N. (2005). Pattern of local recurrence after conservative surgery and whole-breast irradiation. International Journal of Radiation Oncology, Biology & Physics, 61, 1328-36.
• Buyyounouski MK, Hanlon A., Horwitz EM, Uzzo RG, Pollack A. (2005). Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation. International Journal of Radiation Oncology, Biology, & Physics, 61, 1291-8.
• Feigenberg SJ, Hanlon A., Horwitz EM, Uzzo RG, Eisenberg DF, Pollack A. (2005). What pretreatment prostate-specific antigen level warrants long-term androgen deprivation? International Journal of Radiation Oncology, Biology, & Physics, 61, 1003-1010.
• Goldberg M, Gupta D, Sasson AR, Movsas B, Langer CJ, Hanlon A., Wang H, Scott WJ, (2005). The surgical management of superior sulcus tumors: a retrospective review with long-term follow-up. Annals of Thoracic Surgery, 79, 1174-9.
• Konski A, Doss M, Milestone B, Haluszka O, Hanlon A. Freedman G, Adler L. (2005). The integration of 18-fluoro-deoxy-glucose position emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. International Journal of Radiation Oncology, Biology, & Physics, 61, 1123-1128.
• Jacob R, Hanlon A., Horwitz EM, Movsas B, Uzzo RG, Pollack A. (2005). Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement. International Journal of Radiation Oncology, Biology, & Physics, 61, 695-701.
• Buyyounouski MK, Hanlon A., Price RA, Horwitz EM, Feigenberg SJ, Pollack A. (2004). In regard to Selek, et al Erectile dysfunction and radiation dose to penile base structures: a lack of correlation. IJROBP 2004;59:1039-1046. International Journal of Radiation Oncology, Biology, & Physics, 60, 1664-5; author reply 1666.
• Skaleric U, Schara R, Medvescek M, Hanlon A. Doherty F, Lessem J. (2004). Periodontal treatment by arestin and its effects on glycemic control in type 1 diabetes patients. Journal of the International Academy of Periodontology, 6(4S), 160-5.
• Lessem J, Hanlon A. (2004). A post-marketing study of 2805 patients treated for periodontal disease with arestin. Journal of the International Academy of Periodontology, 6(4S), 150-3.
• Anderson PR, Hanlon A., Freedman G, Nicolaou N. (2004). Parity confers better prognosis in older women with early-stage breast cancer treated with breast-conserving therapy. Clinical Breast Cancer, 5, 225-31.
• Anderson PR, Hanlon A., Fowble BL, McNeeley SW, Freedman G. (2004). Low complication rates are achievable after postmastectomy breast reconstruction and radiation therapy. International Journal of Radiation Oncology, Biology, & Physics, 59, 1080-7.
• Kramer NM, Horwitz EM, Uzzo RG, Hanlon A., Hanks GE. (2004). Matched-cohort analysis of patients with prostate cancer followed with observation or treated with three-dimensional conformal radiation therapy. British Journal of Urology International, 94(1), 59-62.
• Paquette DW, Hanlon A., Lessem J, Williams RC. (2004). Clinical relevance of adjunctive minocycline microspheres in patients with chronic periodontitis: secondary analysis of a phase 3 trial.  Journal of Periodontology, 75(4), 531-6.
• Andrews SF, Anderson PR, Eisenberg BL, Hanlon A., Pollack A. (2004). Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy. International Journal of Radiation Oncology, Biology, & Physics, 59, 475-80.
• Chism DB, Hanlon A., Horwitz EM, Feigenberg SJ, Pollack A. (2004). A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy. International Journal of Radiation Oncology, Biology, & Physics, 59, 380-5.
• Uzzo RG, Brown JG, Horwitz EM, Hanlon A., Mazzoni S, Konsk A, Greenberg RE, Pollack A, Kolenko V, Watkins-Bruner D. (2004). Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer. British Journal of Urology International, 93(7), 955-60.
• Buyyounouski MK, Horwitz EM, Uzzo RG, Price RA, McNeeley SW, Azizi D, Hanlon A., Milestone BN, Pollack A. (2004). The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy. International Journal of Radiation Oncology, Biology, & Physics, 59, 1383-91.
• Buyyounouski MK, Horwitz EM, Hanlon A., Uzzo RG, Pollack A. (2004). Re: improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the search database. Journal of Urology, 171, 1246-7; author reply 1247.
• Buyyounouski MK, Horwitz EM, Price RA, Hanlon A., Uzzo RG, Pollack A. (2004). Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment. International Journal of Radiation Oncology, Biology, & Physics, 58, 743-749.
• Hanlon A., Horwitz EM, Hanks GE, Pollack A. (2004). Short-term androgen deprivation and PSA doubling time: Their association and relationship to disease progression after radiation therapy for prostate cancer. International Journal of Radiation Oncology, Biology, & Physics, 58, 43-52.
• Jacob R, Hanlon A., Horwitz EM, Movsas B, Uzzo RG, Pollack A. (2004). The relationship of increasing radiotherapy dose to reduced distance metastases and mortality in men with prostate cancer. Cancer, 100, 538-542.
• Pollack A, Hanlon A., Horwitz EM, Feigenberg SJ, Uzzo RG, Hanks GE. (2004). Prostate cancer radiotherapy dose response: An update of the fox chase experience. Journal of Urology, 171, 1132-1136.
• Bruner DW, Hanlon A., Mazzoni S, Raysor S, Konski A, Hanks GE, Pollack A. (2004). Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer. International Journal of Radiation Oncology, Biology, & Physics, 58, 34-42.
• Nguyen KH, Freedman GM, Hanlon A., Nicolaou N, Anderson PR. (2003). Smoking cessation confers survival advantage for breast cancer patients treated with conservative surgery and radiation. International Journal of Radiation Oncology, Biology, & Physics, 57, S358-359.
• Nguyen KH, Horwitz EM, Hanlon A., Uzzo RG, Pollack A. (2003). Does short-term androgen deprivation substitute for radiation dose in the treatment of high-risk prostate cancer? International Journal of Radiation Oncology, Biology, & Physics, 57, 377-383.
• Pollack A, Hanlon A. Horwitz EM, Feigenberg S, Uzzo RG, Price RA. (2003). Radiation therapy dose escalation for prostate cancer: a rationale for IMRT. World Journal of Urology, 21, 200-208.
• Freedman GM, Anderson PR, Goldstein LJ, Hanlon A., Cianfrocca ME, Millenson MM, von Mehren M, Torosian MH, Boraas MC, Nicolaou N, Patchefsky AS, Evers K. (2003). Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older. Cancer, 98, 918-925.
• Kaminski JM, Hanlon A., Joon DL, Meistrich M, Hachem P, Pollack A. (2003). Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth. International Journal of Radiation Oncology, Biology, & Physics, 57, 24-28.
• Pollack A, Hanlon A., Movsas B, Hanks GE, Uzzo R, Horwitz EM. (2003). Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. International Journal of Radiation Oncology, Biology, & Physics, 57, 19-23.
• Buyyounouski MK, Horwitz EM, Hanlon A., Uzzo RG, Hanks GE, Pollack A. (2003). Positive prostate biopsy laterality and implications for staging. Urology, 62, 298-303.
• Le Voyer TE, Sigurdson ER, Hanlon A., Mayer RJ, MacDonald JS, Catalano PJ, Haller DG. (2003). Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. Journal of Clinical Oncology, 21, 2912-2919.
• Chism DB, Hanlon A., Troncoso P, Al-Saleem T, Horwitz EM, Pollack A. (2003). The Gleason score shift: score four and seven years ago. International Journal of Radiation Oncology, Biology & Physics, 56, 1241-1247.
• Horwitz EM, Uzzo RG, Hanlon A., Greenberg RE, Hanks GE, Pollack A. (2003). Modifying the american society for therapeutic radiology and oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone. Journal of Urology, 169, 2153-2159.
• Pollack A, Horwitz EM, Movsas B, Hanlon A.. (2003). Mindless or mindful? Radiation oncologists’ perspectives on the evolution of prostate cancer treatment. Urologic Clinics of North America, 30, 337-349.
• Joseph NE, Sigurdson ER, Hanlon A., Wang H, Mayer RJ, MacDonald JS, Catalano PJ, Haller DG. (2003). Accuracy of determining nodal negativity in colorectal cancer on the basis of number of nodes retrieved on resection. Annals of Surgical Oncology, 10, 213-218.
• Horwitz EM, Mitra RK, Uzzo RG, Das IJ, Pinover WH, Hanlon A., McNeeley SW, Hanks GE. (2003). Impact of target volume coverage with RTOG 98-05 guidelines for transrectal ultrasound guided permanent I-125 prostate implants. Radiotherapy & Oncology, 66, 173-179.
• Pinover WH, Hanlon A., Horwitz EM, Uzzo RG, Hanks GE. (2003). Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy. Cancer, 97, 1127-1133.
• Chism D, Horwitz EM, Hanlon A., Pinover WH, Mitra RK, Hanks GE. (2003). Late morbidity profiles in prostate cancer patients treated to 79-84 by a simple four-field coplanar beam arrangement.  International Journal of Radiation Oncology, Biology, & Physics, 55, 71-77.
• Pingpank JF, Sasson AR, Hanlon A., Friedman CD, Ridge JA. (2002). Tumor above the spinal accessory nerve in papillary thyroid cancer that Involves lateral neck nodes: A common occurrence. Archives of Otolaryngology- Head & Neck Surgery, 128, 1275-1278.
• Vicini FA, Martinez A, Hanks G, Hanlon A. Miles B, Kernan K, Beyers D, Ragde H, Forman J, Fontanesi J, Kestin L, Kovacs G, Denis L, Slawin K, Scardino P. (2002). An inter-institutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up. Cancer, 95, 2126-2135.
• Hanks GE, Hanlon A., Epstein B, Horwitz EM. (2002). Dose response in prostate cancer with 8-12 years follow-up. International Journal of Radiation Oncology, Biology, & Physics, 54, 427-435.
• Movsas B, Chapman JD, Hanlon A., Horwitz EM, Greenberg RE, Stobbe C, Hanks GE, Pollack A. (2002). Hypoxic prostate/muscle pO₂ ratio predicts for biochemical failure in patients with prostate cancer: Preliminary findings. Urology, 60, 634-639.
• Freedman G, Hanlon A., Fowble B, Anderson PR, Nicolaou N. (2002). Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation. Journal of Clinical Oncology, 20, 4015-4021.
• Mah D, Freedman G, Milestone B, Hanlon A. Palacio E, Richardson T, Movsas B, Mitra R, Horwitz E, Hanks GE. (2002). Measurement of intrafractional prostate motion using magnetic resonance imaging. International Journal of Radiation Oncology, Biology, & Physics, 54, 568-575.
• Mah D, Steckner M, Hanlon A. Freedman G, Milestone B, Mitra R, Shukla H, Movsas B, Horwitz E, Vaisanen PP, Hanks GE. (2002). MRI simulation: Effect of gradient distortions on three dimensional prostate cancer plans. International Journal of Radiation Oncology, Biology, & Physics, 53, 757-765.
• Kramer NM, Hanlon A., Horwitz EM, Pinover WH, Hanks GE. (2002). Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with three dimensional conformal radiation therapy. International Journal of Radiation Oncology, Biology, & Physics, 53, 277-281.
• Simpson PJ, Miller I, Moon C, Hanlon A., Liebl DJ, Ronnett GV. (2002). Atrial natriuretic peptide type C induces a cell-cycle switch from proliferation to differentiation n brain-derived neurotrophic factor- or nerve growth factor-primed olfactory receptor neurons. Journal of Neuroscience, 22, 5536-5551.
• Hanlon A., Diratzouian H, Hanks GE. (2002). Post-treatment PSA nadir is highly predictive of distant failure and ultimate death due to prostate cancer. International Journal of Radiation Oncology, Biology, & Physics, 53, 297-303.
• Fowble B, Hanlon A., Freedman G, Nicolaou N, Anderson PR. (2001). Second cancers after conservative surgery and radiation for stages I-II breast cancer: Identifying a subset of women at increased risk. International Journal of Radiation Oncology, Biology, & Physics, 51, 679-690.
• Kaminskim JM, Hanlon A., Horwitz EM, Pinover WH, Mitra RK, Hanks GE. (2002) Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control. International Journal of Radiation Oncology, Biology, & Physics, 52, 888-892.
• Winter DL, Hanlon A., Raysor SL, Watkins-Bruner DW, Pinover WH, Hanks GE, Tricoli JV. (2001). Plasma levels of IGF-1, IGF-2 and IGFBP-3 in white and african-american men at increased risk for prostate cancer. Urology, 58, 614-618.
• Movsas B, Chapman JD, Hanlon A., Horwitz EM, Pinover WH, Greenberg RE, Stobbe C, Hanks GE. (2001). Hypoxia in human prostate carcinoma: An eppendorf PO₂ study. American Journal of Clinical Oncology, 24, 458-461.
• Horwitz EM, Hanlon A., Pinover WH, Anderson PR, Hanks, GE. (2001). Defining the optimal radiation dose with 3D conformal radiation therapy for patients with non-metastatic prostate cancer using recursive partitioning techniques. Cancer, 92, 1281-1287.
• Mah D, Steckner M, Hanlon A. Freedman G, Milestone B, Mitra R, Shukla H, Movsas B, Horwitz E, Vaisanen PP, Hanks GE. (2002). MRI simulation: Effect of gradient distortions on three- dimensional prostate cancer plans. International Journal of Radiation Oncology, Biology, & Physics, 53, 757-765.
• Mah D, Freedman G, Movsas B, Hanlon A., Mitra R, Horwitz EM, Pinover WH, Iyer R, Hanks GE. (2001). To move or not to move: Measurements of prostate motion by urethrography using MRI.  International Journal of Radiation Oncology, Biology, & Physics, 50, 947-951.
• Hanlon A., Pinover WH, Horwitz EM, Hanks GE. (2001). Patterns and fate of PSA bouncing following 3DCRT. International Journal of Radiation Oncology, Biology, & Physics, 50, 845-849.
• Hanks GE, Hanlon A., Horwitz EM. (2001). Evidence for cure of young men with prostate cancer.  Oncology, 15, 563-570.
• Sasson A, Fowble B, Torosian M, Freedman G, Hanlon A., Boraas M, Sigurdson E, Hoffman J, Eisenberg B. (2001). Lobular carcinoma in situ increases risk of local recurrence in patients treated with breast conservation. Cancer, 91, 1862-1869.
• Cvetkovic D, Movsas B, Dicker AP, Hanlon A., Greenberg RE, Chapman JD, Hanks GE Tricoli JV. (2001). Increased hypoxia correlates with increased expression of the angiogenesis marker VEGF in human prostate cancer. Urology, 57, 821-825.
• Hanlon A., Bruner DW, Peter R, Hanks GE. (2001). Quality of life study in prostate cancer patients treated with three dimensional conformal radiation therapy: Comparing late bowel and bladder quality of life symptoms to that of the normal population. International Journal of Radiation Oncology, Biology, & Physics, 49, 51-59.
• Jordan JJ, Hanlon A., Al-Saleem TI, Greenberg RE, Tricoli JV. (2001). Loss of the short arm of the Y chromosome in human prostate carcinoma. Cancer Genetics & Cytogenetics, 124, 122-126.
• Sasson AR, Pingpank JF, Wetherington RW, Hanlon A., Ridge JA. (2001). Incidental parathyroidectomy during thyroid surgery does not cause transient symptomatic hypocalcemia.  Archives of Otolaryngology- Head & Neck Surgery, 127, 304-308.
• Movsas B, Chapman JD, Greenberg RE, Hanlon A., Horwitz EM, Pinover WH, Stobbe C, Hanks GE. (2000). Increasing levels of hypoxia in human prostate carcinoma correlate significantly with increasing clinical stage and age: An Eppendorf pO₂ Study. Cancer, 89, 2018-2024.
• Anderson PR Hanlon A., Horwitz EM, Pinover WH, Hanks GE. (2000). Outcome and predictive factors for patients with gleason score 7 prostate carcinoma treated with three-dimensional conformal external beam radiation therapy. Cancer, 89, 2565-2569.
• Lattanzi JP, McNeeley SW, Donnelly S, Palacio E, Hanlon A., Schultheiss TE, Hanks GE. (2000). Ultrasound-based stereotactic guidance in prostate cancer-quantification of motion and set-up errors in external beam radiation therapy. Computer Aided Surgery, 5, 289-295.
• Lattanzi JP, McNeeley SW, Hanlon A., Schultheiss TE, Hanks GE. (2000). Ultrasound-based stereotactic guidance of precision conformal external beam radiation therapy in clinically localized prostate cancer. Urology, 55, 73-78.
• Padmore RF, Fowble B, Hoffman J, Rosser C, Hanlon A., Patchefsky AS. (2000). Micoinvasive breast carcinoma: Clinicopathologic analysis of a single institutional experience. Cancer, 88, 1403-1409.
• Pinover WH, Hanlon A., Horwitz EM, Hanks GE. (2000). Defining the appropriate dose for pretreatment PSA <10 ng/ml. International Journal of Radiation Oncology, Biology, & Physics, 47, 649-654.
• Iyer R, Hanlon A., Fowble B, Freedman G, Nicolaou N, Anderson P, Hoffman JP, Sigurdson E, Boraas M, Torosian M. (2000). Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes and number of nodes examined. International Journal of Radiation Oncology, Biology, & Physics, 47, 1177-1183.
• Fowble B, Hanlon A., Freedman G, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Torosian M, Goldstein L. (2000). Internal mammary node irradiation does not decrease distant metastases or improve survival in stage I and II breast cancer. International Journal of Radiation Oncology, Biology, & Physics, 47, 883-894.
• Hanlon A., Hanks GE. (2000). Failure pattern implications following external beam irradiation of prostate cancer: Long term follow-up and indications of cure. Cancer, S2, S193-S197.
• Hanks GE, Hanlon A., Pinover WH, Horwitz EM, Price RA, Schultheiss TE. (2000). Dose selection for prostate cancer patients based on dose comparison and dose response studies.  International Journal of Radiation Oncology, Biology, & Physics, 46, 823-832.
• Hanlon A., Hanks GE. (2000). Failure patterns and hazard rates for failure suggest the cure of prostate cancer by external beam radiation. Urology, 55, 725-729.
• Hanlon A., Hanks, GE. (2000). Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness. International Journal of Radiation Oncology, Biology, & Physics, 46, 559-556.
• Horwitz EM, Hanlon A., Pinover WH, Hanks GE. (1999). Is there a role for short-term hormone use in the treatment of non-metastatic prostate cancer? Radiation Oncology Investigations, 7, 249-259.
• Algan O, Pinover WH, Hanlon A., Al-Saleem TI, Hanks GE. (1999). Is there a subset of patients with PSA >20 ng/ml who do well after conformal beam radiotherapy? Radiation Oncology Investigations, 7,106-110.
• Hanks GE, Hanlon A., Pinover WH, Horwitz EM, Schultheiss TE. (1999). Survival advantage for prostate cancer patients treated with high dose three dimensional conformal radiotherapy. The Cancer Journal from Scientific American, 5, 152-158.
• Tricoli JV, Winter DL, Hanlon A., Raysor SL, Watkins-Bruner D, Pinover WH, Hanks GE. (1999). Racial differences in insulin-like growth factor binding protein 3 in men at increased risk for prostate cancer. Urology, 54, 178-182.
• Movsas B, Chapman JD, Horwitz EM, Pinover WH, Greenberg RE, Hanlon A., Iyer R, Hanks GE. (1999). Hypoxic regions exist in human prostate carcinoma. Urology, 53,11-18.
• Iyer RV, Hanlon A., Pinover WH, Hanks GE. (1999). Outcome evaluation of the 1997 american joint committee on cancer staging system for prostate carcinoma treated by radiation therapy. Cancer, 85, 1816-1821.
• Fowble BL, Hanlon A., Freedman GM, Nicolaou N, Kessler H, Patchefsky A, Hoffman JP, Sigurdson ER, Boraas M, Goldstein LJ. (1999). Postmenopausal hormone replacement therapy (HRT): Effect on diagnosis and outcome in early stage invasive breast cancer treated with conservative surgery and radiation. Journal of Clinical Oncology, 17, 1680-1688.
• Horwitz EM, Hanlon A., Pinover WH, Hanks GE. (1999). The cost-effectiveness of 3D conformal Radiation therapy compared with conventional techniques for patients with clinically localized prostate cancer. International Journal of Radiation Oncology, Biology, & Physics, 45, 1219-1225.
• Freedman GM, Fowble BL, Hanlon A., Fein DA, Nicolaou N, Hoffman JP, Sigurdson ER, Boraas M, Goldstein LJ. (1999). Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. International Journal of Radiation Oncology, Biology, & Physics, 44,1005-1015.
• Herold DM, Hanlon A., Hanks GE. (1999). Diabetes mellitus: A predictor for late radiation morbidity.  International Journal of Radiation Oncology, Biology, & Physics, 43, 475-479.
• Horwitz EM, Hanlon A., Hanks GE. (1998). Update on the treatment of prostate cancer with external beam irradiation. The Prostate, 37, 195-206.
• Hanlon A., Hanks GE. (1998). Patterns of inheritance and outcome in prostate cancer. Urology, 52, 735-738.
• Green GA, Hanlon A., Al-Saleem TI, Hanks GE. (1998). A gleason score of 7 predicts for a worse outcome in patients treated with conformal 3-D radiotherapy for prostate cancer. Cancer, 83, 971-976.
• Wurzer JC, Al-Saleem TI, Hanlon A., Freedman GM, Patchefsky A, Hanks GE. (1998). Histopathologic reviews of prostate biopsies from patients referred to a comprehensive cancer center: Correlation of pathologic findings, analysis of cost, and impact on treatment. Cancer, 83, 753-759.
• Hanlon A., Moore DF, Hanks GE. (1998). Modeling post-radiation PSA level kinetics: Predictors of rising post-nadir slope suggest cure in men who remain biochemically free of prostate cancer. Cancer, 83, 130-134.
• Herold DM, Hanlon A., Movsas B, Hanks GE. (1998). Age-related prostate cancer metastases.  Urology, 51, 985-990.
• Fowble BL, Hanlon A., Patchefsky A, Hoffman JP, Sigurdson ER, Goldstein LJ. (1998). The presence of proliferative breast disease with atypia does not influence outcome in invasive breast cancer treated with conservative surgery and radiation.  International Journal of Radiation Oncology, Biology, & Physics, 42, 105-115.
• Movsas B, Hanlon A., Lanciano RM, Scher RM, Weiner LM, Sigurdson ER, Hoffman JP, Cooper HS, Provins S, Coia LR. (1998). Phase I dose escalating trial of hyperfractionated pre-operative chemo-radiation for locally advanced rectal cancer. International Journal of Radiation Oncology, Biology, & Physics, 42, 43-50.
• Anderson PR, Hanlon A., Patchefsky A, Al-Saleem T, Hanks GE. (1998). Perineural invasion and gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy. International Journal of Radiation Oncology, Biology, & Physics, 41, 1087-1092.
• Lattanzi JP, McNeeley SW, Hanlon A., Das I, Schultheiss TE, Hanks GE. (1998). Daily CT localization for correcting portal errors in the treatment of prostate cancer. (1998). International Journal of Radiation Oncology, Biology, & Physics, 41, 1079-1086.
• Freedman GM, Fowble FL, Hanlon A., Myint MA, Hoffman JP, Sigurdson ER, Eisenberg BL, Goldstein LJ, Fein DA. (1998). A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. International Journal of Radiation Oncology, Biology, & Physics, 41, 599-605.
• Horwitz EM, Hanlon A., Pinover WH, Hanks GE. (1998). The treatment of non-palpable PSA detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy.  International Journal of Radiation Oncology, Biology, & Physics, 41, 519-524.
• Hanks GE, Hanlon A., Schultheiss TE, Pinover WH, Movsas B, Epstein BE, Hunt MA. (1998). Dose escalation with 3-D conformal treatment: Five year outcomes, treatment optimization and future directions. International Journal of Radiation Oncology, Biology, & Physics, 41, 501-510.
• Katz A, Hanlon A., Lanciano RM, Hoffman JP, Coia LR. (1998). Prognostic value of CA 19-9 levels in patients with carcinoma of the pancreas treated with radiotherapy. International Journal of Radiation Oncology, Biology, & Physics, 41, 393-396.
• Movsas B, Hanlon A., Hanks GE. (1998). Is there an increased risk of second primaries following prostate irradiation? International Journal of Radiation Oncology, Biology, & Physics, 41, 251-256.
• Siegelmann-Danieli N, Hanlon A., Ridge JA, Padmore R, Fein DA, Langer CJ. (1998). Oral tongue cancer in thirty young individuals: Institutional experience and comparison with older patients.  Journal of Clinical Oncology, 16, 745-753.
• Freedman GM, Fowble BL, Hanlon A., Fein DA, Hoffman, JP, Sigurdson ER, Goldstein LJ. (1997). Post-mastectomy radiation and adjuvant systemic therapy: Outcomes in high risk women with stage II-III breast cancer and assessment of clinical, pathologic and treatment-related factors influencing local-regional control. The Breast Journal, 3, 337-344.
• Fein DA, Fowble BL, Hanlon A., Hooks MA, Hoffman JP, Sigurdson ER, Jardines LA, Eisenberg BL. (1997). Identification of a group of women with T1-T2 breast cancer at low risk for positive axillary nodes. Journal of Surgical Oncology, 65, 34-39.
• Hanks GE, Hanlon A., Schultheiss TE, Freedman GM, Hunt MA, Pinover WH, Movsas B. (1997). Conformal external beam treatment of prostate cancer. Urology, 50, 87-92.
• Fein DA, Hanlon A., Lee WR, Ridge JA, Coia LR. (1997). Neck failure in T2N0 squamous cell carcinoma of the true vocal cords: The fox chase experience and review of the literature.  American Journal of Clinical Oncology, 20, 154-157.
• Movsas B, Hanlon A., Teshima T, Hanks GE. (1997). Analyzing predictive models following definitive radiotherapy for prostate cancer. Cancer, 80, 1093-1102.
• Bonin SF, Hanlon A., Lee WR, Movsas B, Al-Saleem TI, Hanks GE. (1997). Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy. Cancer, 79, 75-80.
• Lee WR, Hanks GE, Hanlon A., Schultheiss TE. (1997). Rising PSA profile following definitive radiation therapy for localized prostate cancer: Clinical observations. Journal of Clinical Oncology, 15, 230-238.
• Hanks GE, Hanlon A., Pinover WH, Al-Saleem TI, Schultheiss TE. (1997). Radiation therapy as treatment for stage T1C prostate cancers. World Journal of Urology, 15, 369-372.
• Smith AR, Gerber RL, Hughes DB, Kline RW, Kutcher GJ, Ling CC, Hanlon A., Owen JB, Hanks GE. (1997). Assessment of physics quality assurance in united states radiotherapy facilities and comparison with american college of radiology standard for radiation oncology physics for external beam therapy. Seminars in Radiation Oncology, 7, 157-162.
• Herold DH, Hanlon A., Movsas B, Hanks GE. (1997). Post-treatment PSA nadirs support continuing dose escalation study in patients with pretreatment PSA levels >10 ng/ml, but not in those with PSA <10 ng/ml. Radiation Oncology Investigations, 5, 15-19.
• Anderson PR, Hanlon A., Movsas B, Hanks GE. (1997). Androgen deprivation improves bNED survival in specific subsets of prostate cancer patients treated with external beam radiation therapy. International Journal of Radiation Oncology, Biology, & Physics, 39, 1025-1030.
• Teshima T, Hanks GE, Hanlon A., Peter RS, Schultheiss TE. (1997). Rectal bleeding after conformal 3D treatment of prostate cancer: Time to occurrence, response to treatment, and duration of morbidity. International Journal of Radiation Oncology, Biology, & Physics, 39, 77-83.
• Fowble BL, Hanlon A., Fein DA, Hoffman JP, Sigurdson ER, Patchefsky A, Kessler H. (1997). Results of conservative surgery and radiation for mammographically detected ductal carcinoma In-Situ (DCIS). International Journal of Radiation Oncology, Biology, & Physics, 38, 949-957.
• Lattanzi J, Hanlon A., Hanks GE. (1997). Early stage prostate cancer treated with radiation therapy: Stratifying an intermediate risk group. International Journal of Radiation Oncology, Biology, & Physics, 38, 569-574.
• Hanlon A., Schultheiss TE, Hunt MA, Movsas B, Peter RS, Hanks GE. (1997). Chronic rectal bleeding after high dose conformal treatment of prostate cancer warrants modification of existing Morbidity Scales. International Journal of Radiation Oncology, Biology, & Physics, 38, 59-63.
• Hanks GE, Schultheiss TE, Hanlon A., Hunt MA, Lee WR, Epstein BE, Coia LR. (1997). Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study. International Journal of Radiation Oncology, Biology, & Physics, 37, 543-550.
• Kline RW, Coia LR, Smith AR, Owen JB, Hanlon A., Wallace M, Hanks GE. (1997). Treatment planning for adenocarcinoma of the rectum and sigmoid: A patterns of care study.  International Journal of Radiation Oncology, Biology, & Physics, 37, 305-311.
• McGee KP, Fein DA, Hanlon A., Schultheiss TE, Fowble BL. (1997). The value of setup portal films as an estimate of a patient’s position throughout fractionated tangential breast irradiation: An on-line study. International Journal of Radiation Oncology, Biology, & Physics, 37, 223-228.
• Schultheiss TE, Lee WR, Hunt MA, Hanlon A., Peter RS, Hanks GE. (1997).  Late GI and GU complications in the treatment of prostate cancer. International Journal of Radiation Oncology, Biology, & Physics, 37, 3-11.
• Pinover WH, Hanlon A., Lee WR, Kaplan EJ, Hanks GE. (1996). Prostate cancer patients upstaged by imaging and treated with irradiation: An outcome based analysis. Cancer, 77, 1334-1341.
• Hanks GE, Hanlon A., Hudes G, Lee WR, Suasin W, Schultheiss TE. (1996). Patterns-of-failure analysis of patients with high pretreatment PSA treated by radiation therapy: The need for improved systemic and loco-regional treatment. Journal of Clinical Oncology, 14, 1093-1097.
• Lee WR, Hanlon A., Hanks GE. (1996). Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: The relationship between nadir level and disease-free survival. Journal of Urology, 156, 450-453.
• Hood-Hanks S, Hanlon A., Hanks GE. (1996). Quantitating regrowth delay of prostate cancers after failure of radiation therapy. Radiology, 200, 505-508.
• Lee WR, Hanlon A., Hanks GE. (1996). Systematic biopsies: Do they add prognostic information in men with clinically localized prostate cancer treated with radiation therapy alone? Radiology, 198, 439-442.
• Lee WR, Hanks GE., Hanlon A., Schultheiss TE. (1996). Pretreatment serum prostate-specific antigen (PSA) level and PSA doubling times (PSADT) in black and white men with prostate cancer referred for radiation therapy. Radiation Oncology Investigations, 4, 135-139.
• Lee WR, Schultheiss TE, Hanlon A., Hanks GE. (1996). Urinary incontinence following external beam radiotherapy for clinically localized prostate cancer. Urology, 48, 95-99.
• Lee WR, Hanlon A., Hank GE. (1996). Do the results of systematic biopsies predict outcome in patients with T1-T2 prostate cancer treated with radiation therapy alone? Urology, 47, 704-707.
• Kutcher GJ, Smith AR, Fowble BF, Gerber RL, Hughes DB, Kline RW, Ling CC, Owen JB, Hanlon A., Wallace M, Hanks GE. (1996). Treatment planning for primary breast cancer: A patterns of care study. International Journal of Radiation Oncology, Biology, & Physics, 36, 731-737.
• Fein DA, Hanlon A., Corn B, Curran WJ, Coisa LR. (1996). The influence of lymphangiography on the development of hypothyroidism in patients irradiated for hodgkin’s disease. International Journal of Radiation Oncology, Biology, & Physics, 36, 13-18.
• Algan O, Tabesh T, Hanlon A., Hogan WM, Boente, M, Lanciano RM. (1996). Superior outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer. International Journal of Radiation Oncology, Biology, & Physics, 35, 925-933.
• Hanks GE, Lee WR, Hanlon A., Hunt MA, Kaplan E, Epstein BE, Movsas B, Schultheiss TE. (1996). Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen >10 ng/mL.  International Journal of Radiation Oncology, Biology, & Physics, 35, 861-868.
• Fowble BL, Fein DA, Hanlon A., Eisenberg BL, Hoffman JP, Sigurdson ER, Daly MB, Goldstein LJ. (1996). The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor positive early stage breast cancer. International Journal of Radiation Oncology, Biology, & Physics, 35, 669-677.
• Lee WR, Hanks GE, Hanlon A., Schultheiss TE, Hunt MA. (1996). Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect. International Journal of Radiation Oncology, Biology, & Physics, 35, 251-257.
• Freedman GM, Hanlon A., Lee WR, Hanks GE. (1996). Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation. International Journal of Radiation Oncology, Biology, & Physics, 35, 243-250.
• Fein DA, Fowble BL, Hanlon A., Hoffman JP, Sigurdson ER, Eisenberg BL. (1996). Does the placement of surgical clips within the excision cavity influence local control for patients treated with breast conserving surgery and irradiation? International Journal of Radiation Oncology, Biology, & Physics, 34, 1009-1017.
• Fein DA, Lee WR, Hanlon A., Ridge JA, Curran WJ, Coia LR. (1996). Do overall treatment time, field size and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx? International Journal of Radiation Oncology, Biology, & Physics, 34, 823-831.
• Hanks GE, Hanlon A., Lee WR, Slivjak A, Schultheiss TE. (1996). Pretreatment PSA doubling times: Clinical utility of this predictor of prostate cancer behavior. International Journal of Radiation Oncology, Biology, & Physics, 34, 549-553.
• Ling CC, Smith AR, Hanlon A., Owen JB, Brickner TJ, Hanks GE. (1996). Treatment planning for carcinoma of the cervix: A patterns of care study report. International Journal of Radiation Oncology, Biology, & Physics, 34, 13-19.
• Fein DA, Lee WR, Hanlon A., Ridge JA, Langer CJ, Curran WJ, Coia LR. (1995). Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. Journal of Clinical Oncology, 13, 2077-2083.
• Hanks GE, Corn BW, Lee WR, Hunt MA, Hanlon A., Schultheiss TE. (1995). External beam irradiation of prostate cancer: Conformal treatment techniques and outcomes for the 1990’s. Cancer Supplement, 75, 1972-1977.
• Fein DA, Corn BW, Hanlon A., Curran WJ, Coia LR. (1995). Acute parotitis during mantle irradiation: Incidence, onset, duration, and treatment. Radiation Oncology Investigations, 2, 291-294.
• Teshima T, Hanlon A., Hanks GE. (1995). Pretreatment prostate-specific antigen values in patients with prostate cancer: 1989 patterns of care study process survey. International Journal of Radiation Oncology, Biology, & Physics, 33, 809-814.
• Gerber RL, Smith AR, Owen JB, Hanlon A., Wallace M, Hanks GE. (1995). Patterns of care survey results: Treatment planning for carcinoma of the prostate. International Journal of Radiation Oncology, Biology, & Physics, 33, 803-808.
• Withers HR, Peters LJ, Taylor JMG, Owen JB, Morrison WH, Schultheiss TE, Keane T, O’Sullivan B, Van Dyk J, Gupta N, Wang C, Jones CU, Doppke KP, Myint S, Thompson M, Parsons JT, Mendenhall WM, Dische S, Aird EGA, Henk JM, Bidmead MAM, Svoboda V, Chon Y, Hanlon A., Peters TL, Hanks GE. (1995). Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: Patterns of fractionation study of radiobiology. International Journal of Radiation Oncology, Biology, & Physics, 33, 563-568.
• Withers HR, Peters LJ, Taylor JMG, Owen JB, Morrison WH, Schultheiss TE, Keane T, O’Sullivan B, Van Dyk J, Gupta, N, Wang C, Jones CU, Doppke KP, Myint S, Thompson M, Parsons JT, Mendenhall WM, Dische S, Aird EGA, Henk JM, Bidmead MAM, Svoboda V, Chon Y, Hanlon A., Peter, TL, Hanks GE. (1995). Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions. International Journal of Radiation Oncology, Biology, & Physics, 33, 549-562.
• Hughes DB, Smith AR, Hoppe RT, Owen JB, Hanlon A., Wallace M, Hanks GE. (1995). Treatment planning for hodgkin’s disease: A patterns of care study. International Journal of Radiation Oncology, Biology, & Physics, 33, 519-523.
• Montana GS, Hanlon A., Brickner TJ, Owen JB, Hanks GE, Ling CC, Komaki R, Marcial VA, Thomas GM, Lanciano RM. (1995). Carcinoma of the cervix: Patterns of care studies review of 1978, 1983, and 1988-1989 surveys. International Journal of Radiation Oncology, Biology, & Physics, 32, 1481-1486.
• Fein DA, Lee WR, Lanciano RM, Corn BW, Herbert SH, Hanlon A., Hoffman JP, Eisenberg BL, Coia LR. (1995). Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: Do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control? International Journal of Radiation Oncology, Biology, & Physics, 32, 969-976.
• Smith AR, Gerber RL, Hughes DB, Kline RW, Kutcher GJ, Ling CC, Owen JB, Hanlon A., Wallace M, Hanks GE. (1995). Treatment planning structure and process in the united states: A patterns of care study. International Journal of Radiation Oncology, Biology, & Physics, 32, 255-262.
• Komaki R, Brickner TJ, Hanlon A., Owen JB, Hanks GE. (1995). Long-term results of treatment of cervical carcinoma in the united states in 1973, 1978, and 1983: A patterns of care study. International Journal of Radiation Oncology, Biology, & Physics, 31, 973-982.
• Hoppe RT, Hanlon A., Owen JB, Hanks GE. (1994). Progress in the treatment of hodgkin’s disease in the united states, 1973 versus 1983: The patterns of care study. Cancer, 74, 3198-3203.
• Hanks GE, Hanlon A., Owen JB, Schultheiss TE. (1994). Patterns of radiation treatment of elderly patients with prostate cancer. Cancer Supplement, 74, 2174-2177.
• Coia LR, Wizenberg MJ, Hanlon A., Gunderson LL, Haller D, Hoffman JP, Kline RW, Mohiuddin M, Russell AH, Tepper JE, Owen JB, Hanks GE. (1994). Evaluation and treatment of patients receiving radiation for cancer of the rectum or sigmoid colon in the united states: Results of the 1988-1989 patterns of care study process survey. Journal of Clinical Oncology, 12, 954-959.
• Corn BW, Hanlon A., Pajak TF, Owen JB, Hanks GE. (1994). Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix. Gynecologic Oncology, 53, 294-300.
• Hanks GE, Krall JM, Hanlon A., Asbell SO, Pilepich MV, Owen JB. (1994). Patterns of care and RTOG studies in prostate cancer: Long-term survival, hazard rate observations, and possibilities of cure. International Journal of Radiation Oncology, Biology, & Physics, 28, 39-45.
• Hanks GE, Hanlon A., Schultheiss TE, Corn BW, Shipley WU, Lee WR. (1994). Early prostate cancer: The national results of radiation treatment from the patterns of care and RTOG studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation. Journal of Urology, 152, 1775-1780.
• Steinfeld A, Hanlon A., Pajak TF, Hanks GE. (1994). Gender as a determinant of palliative radiotherapy: A patterns of care study analysis. Journal of Women’s Health, 3, 85-89.

Chapters in Books:

• Fowble, B.L., Rosser, C. & Hanlon, A.L. (1998). Conservative Surgery and Radiation for Stages I and II Breast Cancer. In Bland, K.I. & Copeland, III, E.M. (Eds.), The Breast: Comprehensive Management of Benign and Malignant Diseases, Second Edition, (pp.1172-1178). Orlando, Florida: W. B. Saunders Company.
• Hanks, G.E., Lee, W.R., Hanlon, A.L. & Schultheiss, T.E. (1995). Prostate Cancer and PSA Doubling Times as an Indicator of Tumor Doubling. In Kogelnik, H.D. (Ed.), Progress in Radio-Oncology V, (pp. 99-103). Bologna, Italy: Salzburg, Austria, Monduzzi Editorie.
• Hanks, G.E., Hanlon, A.L., Lee, W.R., Hunt, M.A. & Schultheiss, T.E. (1995). Conformal Treatment of Prostate Cancer: Effects on Cancer Control and Morbidity. In Kogelnik, H.D. (Ed.), Progress in Radio-Oncology V, (pp. 341-345), Bologna, Italy: Salzburg, Austria, Monduzzi Editorie.